Abstract
Ebola virus disease (EVD) is a complex zoonosis that is highly virulent in humans. The largest recorded outbreak of EVD is ongoing in West Africa, outside of its previously reported and predicted niche. We assembled location data on all recorded zoonotic transmission to humans and Ebola virus infection in bats and primates (1976–2014). Using species distribution models, these occurrence data were paired with environmental covariates to predict a zoonotic transmission niche covering 22 countries across Central and West Africa. Vegetation, elevation, temperature, evapotranspiration, and suspected reservoir bat distributions define this relationship. At-risk areas are inhabited by 22 million people; however, the rarity of human outbreaks emphasises the very low probability of transmission to humans. Increasing population sizes and international connectivity by air since the first detection of EVD in 1976 suggest that the dynamics of human-to-human secondary transmission in contemporary outbreaks will be very different to those of the past.
DOI: http://dx.doi.org/10.7554/eLife.04395.001
Research organism: human, viruses
eLife digest
Since the first outbreaks of Ebola virus disease in 1976, there have been numerous other outbreaks in humans across Africa with fatality rates ranging from 50% to 90%. Humans can become infected with the Ebola virus after direct contact with blood or bodily fluids from an infected person or animal. The virus also infects and kills other primates—such as chimpanzees or gorillas—though Old World fruit bats are suspected to be the most likely carriers of the virus in the wild.
The largest recorded outbreak of Ebola virus disease is ongoing in West Africa: more people have been infected in this current outbreak than in all previous outbreaks combined. The current outbreak is also the first to occur in West Africa—which is outside the previously known range of the Ebola virus.
Pigott et al. have now updated predictions about where in Africa wild animals may harbour the virus and where the transmission of the virus from these animals to humans is possible. As such, the map identifies the regions that are most at risk of a future Ebola outbreak. The data behind these new maps include the locations of all recorded primary cases of Ebola in human populations—the ‘index’ cases—many of which have been linked to animal sources. The data also include the locations of recorded cases of Ebola virus infections in wild bats and primates from the last forty years. The maps, which were modelled using more flexible methods than previous predictions, also include new information—collected using satellites—about environmental factors and new predictions of the range of wild fruit bats.
Pigott et al. report that the transmission of Ebola virus from animals to humans is possible in 22 countries across Central and West Africa—and that 22 million people live in the areas at risk. However, outbreaks in human populations are rare and the likelihood of a human getting the disease from an infected animal still remains very low. The updated map does not include data about how infections spread from one person to another, so the next challenge is to use existing data on human-to-human transmission to better understand the likely size and extent of current and future outbreaks. As more people live in, and travel to and from, the at-risk regions than ever before, Pigott et al. note that new outbreaks of Ebola virus disease are likely to be very different to those of the past.
Introduction
Ebola viruses have for the last forty years been responsible for a number of outbreaks of Ebola virus disease (EVD) in humans (Pattyn et al., 1977), with high case fatality rates typically around 60–70%, but potentially reaching as high as 90% (Feldmann and Geisbert, 2011). The most recent outbreak began in Guinea in December 2013 (Baize et al., 2014; Bausch and Schwarz, 2014) and has subsequently spread to Liberia, Sierra Leone and Nigeria (ECDC, 2014). The unprecedented size and scale of this ongoing outbreak has the potential to destabilise already fragile economies and healthcare systems (Fauci, 2014), and fears of international spread of a Category A Priority Pathogen (NIH, 2014) have made this a massive focus for international public health (Chan, 2014). This has led to the current outbreak being declared a Public Health Emergency of International Concern on the 8 August 2014 (Briand et al., 2014; Gostin et al., 2014; WHO, 2014d).
The Filoviridae, of which Ebolavirus is a constituent genus, belong to the order Mononegavirales. Two other genera complete the family: Marburgvirus, itself responsible for a number of outbreaks of haemorrhagic fever across Africa (Gear et al., 1975; Conrad et al., 1978; Smith et al., 1982; Towner et al., 2006) and Cuevavirus, recently isolated from bats in northern Spain (Negredo et al., 2011). Five species of Ebolavirus have been isolated to date (Kuhn et al., 2010; King et al., 2012); the earliest recognised outbreaks of EVD were reported in Zaire (now the Democratic Republic of the Congo [DRC]) and Sudan in 1976 (International Commission, 1978; WHO International Study Team, 1978). The causative viruses were isolated (Pattyn et al., 1977) and later identified to be distinct species, Zaire ebolavirus (EBOV) and Sudan ebolavirus (SUDV). A third species of Ebolavirus, Reston ebolavirus, was isolated from Cynomologus monkeys imported from the Philippines to a facility in the United States, where they experienced severe haemorrhaging (Jahrling et al., 1990). Whilst serological evidence of infection with this species has been reported in individuals in the Philippines (Miranda et al., 1991), no pathogenicity has been reported beyond primates and porcids (Barrette et al., 2009; Feldmann and Geisbert, 2011). In 1994 a fourth species, Tai Forest ebolavirus was isolated from a veterinarian who had autopsied a chimpanzee in Côte d’Ivoire (Le Guenno et al., 1995), though the virus has not been detected subsequently. The final species, Bundibugyo ebolavirus, was responsible for an outbreak of EVD in Uganda in 2007 (Towner et al., 2008), as well as a more recent outbreak in the DRC (WHO, 2012b).
Initial analysis suggested that the viruses isolated from the current outbreak, originating in Guinea, formed a separate clade within the five Ebolavirus species (Baize et al., 2014). Subsequent re-analysis of the same sequences however, indicated that these isolates instead nest within the Zaire ebolavirus lineage (Dudas and Rambaut, 2014), and diverged from Central Africa strains approximately ten years ago (Gire et al., 2014).
Which reservoir species are responsible for maintaining Ebola transmission between outbreaks is not well understood (Peterson et al., 2004b), but over the last decade significant progress has been made in narrowing down the list of likely hosts (Peterson et al., 2007) (Figure 1). Primates have long been known to harbour filoviral infections, with the first Marburg strains identified in African green monkeys in 1967 (Siegert et al., 1967; Beer et al., 1999). Significant mortality has also been reported in wild primate populations across Africa, most notably in gorilla (Gorilla gorilla) and chimpanzee (Pan troglodytes) populations (Formenty et al., 1999; Rouquet et al., 2005; Bermejo et al., 2006). The high case fatality rates recorded in the great apes combined with their declining populations and limited geographical range, indicate they are likely dead-end hosts for the virus and not reservoir species (Groseth et al., 2007). A large survey of small mammals in and around Gabon identified three species of bats which were infected with Ebola viruses—Hypsignathus monstrosus, Epomops franqueti and Myonycetris torquata (Leroy et al., 2005). Subsequent serological surveys (Pourrut et al., 2009; Hayman et al., 2010) and evidence linking the potential source of human outbreaks to bats (Leroy et al., 2009) lend support to the hypothesis of a bat reservoir. This, coupled with repeated detection of Marburgvirus in the fruit bat Rousettus aegypticus (Towner et al., 2009) and the only isolations of Cuevavirus also from bats (specifically Llovia virus [Negredo et al., 2011]), all support the suspicion that Chiroptera play an important role in the natural life-cycle of the filoviruses.
Humans represent a dead-end host for the virus, with only stuttering chains of transmission reported between humans in the majority of previous outbreaks (Chowell et al., 2004; Legrand et al., 2007) and no indication that humans can reintroduce the virus back into reservoir species (Karesh et al., 2012). The incubation period in humans ranges from two days to three weeks, after which a variety of clinical symptoms arise, affecting multiple organs of the body. At the peak of illness, haemorrhaging shock and widespread tissue damage can occur and can eventually lead to death within 6–16 days (Feldmann and Geisbert, 2011). Human-to-human transmission is mainly through direct unprotected contact with infected individuals and cadavers, with infectious particles detected in a number of different body fluids (Feldmann and Geisbert, 2011). The typical outbreak profile is defined by an index individual that has recently come into contact with the blood of another mammal through either hunting or the butchering of animal carcasses (Pourrut et al., 2005). Whilst it has been difficult to identify the zoonotic source for the index cases of some outbreaks, a recurring theme of hunting and handling bushmeat is suspected (Table 1; Boumandouki et al., 2005; Nkoghe et al., 2005, 2011; Leroy et al., 2009). For some outbreaks, including the most recent, the initial source of zoonotic transmission has not been identified. In subsequent human-to-human transmission, the highest risk activities are those that bring humans into close contact with infected individuals. These include medical settings where insufficient infection control precautions have been taken, as well as home care and funeral preparations carried out by families or close friends (Baron et al., 1983; Georges et al., 1999; Boumandouki et al., 2005). As the conditions required for transmission are culturally and contextually dependent, opportunities for sustained transmission are highly heterogeneously distributed. Typically, chains of infection do not exceed three or four sequential transmission events, although occasionally (and particularly in the early stages of infection) a single individual may be responsible for directly infecting a large number of others (Brady et al., 2014). In the outbreak in Gabon in 1996, a single person was responsible for infecting ten other individuals (Milleliri et al., 2004) whilst in the 1995 outbreak in the DRC, thirty five cases resulted from one individual (Khan et al., 1999). Secondary transmission can be restricted by effective case detection and isolation measures (Shoemaker et al., 2012; WHO, 2014c). Where this cannot be achieved, either due to a lack of infrastructure, poor understanding of the disease, or distrust of medical practices, secondary cases can continue to occur (Khan et al., 1999; Larkin, 2003; Hewlett et al., 2005). As the number of infections grows, the ability of healthcare systems to control the further spread diminishes and the risk of a large outbreak increases.
Table 1.
Outbreak | Countries | Date range | Location | Species | Reference |
---|---|---|---|---|---|
1 | South Sudan | Jun–Nov 1976 | Nzara | SUDV | (WHO International Study Team, 1978) |
2 | DRC | Sep–Oct 1976 | Yambuku | EBOV | (International Commission, 1978) |
3 | DRC | Jun 1977 | Bonduni | EBOV | (Heymann et al., 1980) |
4 | South Sudan | Jul–Oct 1979 | Nzara | SUDV | (Baron et al., 1983) |
5 | Côte d’Ivoire | Nov 1994 | Tai Forest | TAFV | (Le Guenno et al., 1995; Formenty et al., 1999) |
6 | Gabon | Nov 1994–Feb 1995 | Mekouka and Andock mining camps | EBOV | (Amblard et al., 1997; Georges et al., 1999; Milleliri et al., 2004) |
7 | DRC | Jan–Jul 1995 | Mwembe Forest | EBOV | (Muyembe and Kipasa, 1995; Khan et al., 1999) |
8 | Gabon | Jan–Mar 1996 | Mayibout 2 | EBOV | (Georges et al., 1999; Milleliri et al., 2004) |
9 | Gabon | Jul 1996–Jan 1997 | Booue | EBOV | (Georges et al., 1999; Milleliri et al., 2004) |
10 | Uganda | Oct 2000–Feb 2001 | Rwot-Obillo | SUDV | (WHO, 2001; Okware et al., 2002; Lamunu et al., 2004) |
11 | Gabon & ROC | Oct 2001–Mar 2002 | Memdemba Entsiami, Abolo and Ambomi | EBOV | (WHO, 2003; Milleliri et al., 2004; Nkoghe et al., 2005; Pourrut et al., 2005) |
Ekata | |||||
Oloba | |||||
Etakangaye | |||||
Grand Etoumbi | |||||
12 | ROC | Dec 2002–Apr 2003 | Yembelangoye | EBOV | (WHO, 2003; Pourrut et al., 2005) |
Nearby hunting camp | |||||
Mvoula | |||||
13 | ROC | Oct–Dec 2003 | Mbandza | EBOV | (Boumandouki et al., 2005) |
14 | South Sudan | Apr–Jun 2004 | Forests bordering Yambio | SUDV | (WHO, 2005; Onyango et al., 2007) |
15 | ROC | Apr–May 2005 | Odzala National Park | EBOV | (Nkoghe et al., 2011) |
16 | DRC | May–Nov 2007 | Mombo Mounene 2 market | EBOV | (Leroy et al., 2009) |
17 | Uganda | Aug–Dec 2007 | Kabango | BDBV | (Towner et al., 2008; MacNeil et al., 2010; Wamala et al., 2010) |
18 | DRC | Nov 2008–Feb 2009 | Luebo | EBOV | (Grard et al., 2011) |
19 | Uganda | May 2011 | Nakisamata | SUDV | (Shoemaker et al., 2012) |
20 | DRC | July–Nov 2012 | Isiro | BDBV | (CDC, 2014; WHO, 2012b) |
21 | Uganda | July–Oct 2012 | Nyanswiga | SUDV | (CDC, 2014; WHO, 2012a) |
22 | Uganda | Nov 2012–Jan 2013 | Luwero District | SUDV | (WHO, 2012c; CDC, 2014) |
23 | Guinea | Dec 2013 - | Meliandou | EBOV | (Baize et al., 2014; Bausch and Schwarz, 2014) |
DRC = Democratic Republic of the Congo, ROC = Republic of Congo.
The recent outbreak in Guinea and surrounding countries indicate that the previous paradigm for Ebola outbreaks is shifting (Briand et al., 2014; Chan, 2014). The last 40 years of EVD outbreaks were accompanied by considerable changes in demographic patterns throughout Africa. There has been a large increase in population size coupled with increasing urbanisation (Cohen, 2004; Seto et al., 2012; Linard et al., 2013). African populations have also become better connected internally and internationally (Linard et al., 2012; Huang and Tatem, 2013). Only recently have we begun to understand the dynamic nature of these travel patterns (Garcia et al., 2014; Gonzalez et al., 2008; Simini et al., 2012; Wesolowski et al., 2013, 2012) which have been clearly demonstrated to influence disease transmission over different temporal and spatial scales (Hufnagel et al., 2004; Yang et al., 2008; Stoddard et al., 2009; Talbi et al., 2010; Brockmann and Helbing, 2013; Pindolia et al., 2014). Changes in land use and penetration into previously remote areas of rainforest bring humans into contact with potential new reservoirs (Daszak, 2000), while changes in human mobility and connectivity will likely have profound impacts on the dispersion of Ebola cases during outbreaks. These conditions are thought to have a major role in setting the stage for the current outbreak.
This paper aims to define the areas suitable for zoonotic transmission of Ebolavirus (i.e., those routes defined in Figure 1 excluding human-to-human transmission) through species distribution modelling techniques. The fundamental niche of a species can be conceptualised as the confluence of environmental conditions that support its presence in a particular location (Franklin, 2009). Species distribution models quantitatively describe this niche based on known occurrence records of the organism and their associated environmental conditions, enabling predictions of the likely geographic distribution of the species in other regions (Elith and Leathwick, 2009). The era of satellites and geographical information systems has made high resolution global data on environmental conditions increasingly available (Hay et al., 2006; Weiss et al., 2014b). Species distribution modelling using flexible machine learning approaches have been successfully applied to map the global distributions of disease vectors (Sinka et al., 2012) and pathogens such as dengue (Bhatt et al., 2013), influenza (Gilbert et al., 2014) and leishmaniasis (Pigott et al., 2014).
Previous studies applied the GARP (Genetic Algorithm for Rule-set Production) species distribution modelling approach (Stockwell and Peters, 1999) to the locations of 12 Ebola outbreaks in humans between 1976 and 2002 to map the likely distribution of Ebola viruses (Peterson et al., 2004a) and as a mechanism to identify potential reservoir hosts (Peterson et al., 2004b; Peterson et al., 2007). Here we update and improve the maps of the zoonotic transmission niche of EVD by: (i) incorporating more recent outbreak data from outside the formerly predicted niche of EVD; (ii) integrating for the first time data on outbreaks in primates and the occurrence of the virus in the suspected Old World fruit bat (OWFB) reservoirs; (iii) using new satellite-derived information on bespoke environmental covariates from Africa, including new distribution maps of the OWFB; and (iv) using new increasingly flexible niche mapping techniques in the modelling framework. To elucidate the relevance of these maps for transmission, we have also calculated the population at risk of primary spillover outbreaks from the zoonotic niche of EVD in Africa, and we investigated the changing nature of the populations within this niche.
Results
Reported EVD outbreaks
In total, 23 outbreaks of Ebola virus were identified in humans across Africa, consisting of a hypothesised 30 independent primary infection events (Table 1; Figure 2). These outbreaks span the last 40 years from the first outbreaks in 1976 to the five outbreaks that have occurred since 2010 (Table 1). The locations of the index cases span from West Africa, with the most westerly outbreak ongoing in Guinea, to Gabon, the Republic of Congo (ROC), the DRC, South Sudan and Uganda. Before December 2013, a total of 2322 cases had occurred from Ebolavirus infections, a number already overtaken by the likely underreported current case count of the ongoing outbreak >2250 (WHO, 2014a) (Figure 2A). Of the four viruses circulating in Africa, Zaire ebolavirus has been responsible for the most outbreaks (13), followed by Sudan ebolavirus (7) and Bundigbuyo ebolavirus with just two outbreaks in 2007/8 and 2012. Tai Forest has caused one confirmed infection in humans, from which the patient recovered (Le Guenno et al., 1995; Formenty et al., 1999). Although outbreaks have been reported since 1976, there was an absence of reported outbreaks in humans for 15 years between 1979 and 1994 (although antibodies in humans were identified over the period [Kuhn, 2008]) and the frequency of outbreaks has increased substantially post 2000 (Figure 2A).
Reported Ebola virus infections in animals
A total of 51 surveyed locations reporting infections in animals were identified in the literature since the discovery of the disease (Table 2; Figure 3). These comprised 17 infections in gorillas (Gorilla gorilla), nine infections in chimpanzees (Pan troglodytes), 18 in OWFB and 2 in duikers (Cephalophus spp.). A large proportion of the great ape cases originated from the ROC/Gabon border, coinciding with the main known distributions of both chimpanzees and gorillas (Petter and Desbordes, 2013) and representing a period of well-documented great ape Ebola outbreaks in and around the Lossi Animal Sanctuary (Rouquet et al., 2005; Bermejo et al., 2006; Walsh et al., 2009). All animal isolations of Ebola viruses have come from countries that have also reported index cases of human outbreaks, with the exception of several seropositive bats from a survey in southern Ghana.
Table 2.
Site | Country | Date range | Location | Species | Diagnosis | Reference |
---|---|---|---|---|---|---|
1 | Côte d’Ivoire | Oct–Nov 1994 | Tai Forest | Chimpanzee | Serology | (Formenty et al., 1999) |
2 | Gabon | Jan 1996 | Mayiboth 2 | Chimpanzee | PCR | (Lahm et al., 2007) |
3 | Gabon | Jul 1996 | Near Booue | Chimpanzee | Serology | (Georges-Courbot et al., 1997) |
4 | Gabon | Sept 1996 | Lope National Park | Chimpanzee | PCR | (Lahm et al., 2007) |
5 | Gabon & ROC | Aug 2001 | Mendemba/Lossi Animal Sanctuary | Chimpanzee | PCR | (Lahm et al., 2007) |
6 | Gabon & ROC | Aug 2001 | Mendemba/Lossi Animal Sanctuary | Gorilla | PCR | (Lahm et al., 2007) |
7 | Gabon & ROC | Aug 2001 | Mendemba/Lossi Animal Sanctuary | Cephalophus dorsalis | PCR | (Lahm et al., 2007) |
8 | Gabon | Nov 2001 | Zadie | Gorilla | PCR | (Rouquet et al., 2005) |
9 | Gabon | Nov 2001 | Ekata | Gorilla | PCR | (Wittmann et al., 2007) |
10 | Gabon | Dec 2001 | Medemba and neighbouring villages | Chimpanzee and Gorilla | PCR | (Leroy et al., 2002) |
11 | Gabon | Feb 2002 | Zadie | Gorilla | PCR | (Rouquet et al., 2005) |
12 | Gabon | Feb 2002 | Ekata | Various bat species | Serology | (Leroy et al., 2005) |
13 | Gabon | Mar 2002 | Zadie | Gorilla | PCR | (Rouquet et al., 2005) |
14 | Gabon | Mar 2002 | Grand Etoumbi | Gorilla | PCR | (Wittmann et al., 2007) |
15 | Gabon | Apr 2002 | Ekata | Gorilla | PCR | (Wittmann et al., 2007) |
16 | ROC | May 2002 | Oloba | Chimpanzee | PCR | (Lahm et al., 2007) |
17 | ROC | Dec 2002 | Lossi Animal Sanctuary | Gorilla | PCR | (Rouquet et al., 2005) |
18 | ROC | Dec 2002 | Lossi Animal Sanctuary | Gorilla | PCR | (Rouquet et al., 2005) |
19 | ROC | Dec 2002 | Lossi Animal Sanctuary | Chimpanzee | Serology | (Rouquet et al., 2005) |
20 | ROC | Dec 2002 | Lossi Animal Sanctuary | Gorilla | PCR | (Rouquet et al., 2005) |
21 | ROC | Dec 2002 | Lossi Animal Sanctuary | Gorilla | PCR | (Rouquet et al., 2005) |
22 | ROC | Dec 2002 | Lossi Animal Sanctuary | Cephalophus spp. | PCR | (Rouquet et al., 2005) |
23 | Gabon | Feb 2003 | Mbomo | Various bat species | PCR | (Leroy et al., 2005) |
24 | ROC | Feb 2003 | Lossi Animal Sanctuary | Gorilla | Serology | (Rouquet et al., 2005) |
25 | Gabon | Feb 2003 | Lossi Animal Sanctuary | Chimpanzee | PCR | (Wittmann et al., 2007) |
26 | Gabon | Jun 2003 | Mbomo | Various bat species | PCR and serology | (Leroy et al., 2005) |
27 | ROC | Jun 2003 | Near Mbomo and Ozala National Park | Epomops franqueti | Serology | (Pourrut et al., 2009) |
28 | ROC | Jun 2003 | Near Mbomo and Ozala National Park | Hypsignathus monstrosus | Serology | (Pourrut et al., 2009) |
29 | ROC | Jun 2003 | Near Mbomo and Ozala National Park | Myonycteris torquata | Serology | (Pourrut et al., 2009) |
30 | ROC | Jun 2003 | Mbanza | Gorilla | PCR | (Rouquet et al., 2005) |
31 | ROC | Jan–Jun 2004 | Lokoué | Gorilla | Reported | (Caillaud et al., 2006) |
32 | ROC | May 2004 | Lokoué | Gorilla | PCR | (Wittmann et al., 2007) |
33 | Gabon | Feb 2005 | Near Franceville | Epomops franqueti | Serology | (Pourrut et al., 2009) |
34 | Gabon | Feb 2005 | Near Franceville | Myonycteris torquata | Serology | (Pourrut et al., 2009) |
35 | Gabon | Apr 2005 | Near Lambarene | Epomops franqueti and Hypsignathus monstrosus | Serology | (Pourrut et al., 2007) |
36 | ROC | May 2005 | Near Mbomo and Ozala National Park | Epomops franqueti | Serology | (Pourrut et al., 2009) |
37 | ROC | May 2005 | Near Mbomo and Ozala National Park | Hypsignathus monstrosus | Serology | (Pourrut et al., 2009) |
38 | ROC | May 2005 | Near Mbomo and Ozala National Park | Myonycteris torquata | Serology | (Pourrut et al., 2009) |
39 | ROC | Jun 2005 | Odzala National Park | Gorilla | PCR | (Wittmann et al., 2007) |
40 | Gabon | Feb 2006 | Near Tchibanga | Various bat species | Serology | (Pourrut et al., 2009) |
41 | ROC | May 2006 | Near Mbomo and Ozala National Park | Epomops franqueti | Serology | (Pourrut et al., 2009) |
42 | ROC | May 2006 | Near Mbomo and Ozala National Park | Hypsignathus monstrosus | Serology | (Pourrut et al., 2009) |
43 | ROC | May 2006 | Near Mbomo and Ozala National Park | Myonycteris torquata | Serology | (Pourrut et al., 2009) |
44 | Gabon | Oct 2006 | Near Franceville | Epomops franqueti | Serology | (Pourrut et al., 2009) |
45 | Ghana | May 2007 | Sagyimase | Epomops franqueti | Serology | (Hayman et al., 2012) |
46 | Ghana | May 2007 | Sagyimase | Hypsignathus monstrosus | Serology | (Hayman et al., 2012) |
47 | Ghana | May 2007 | Adoagyir | Epomophorus gambianus | Serology | (Hayman et al., 2012) |
48 | Ghana | May 2007 | Adoagyir | Epomops franqueti | Serology | (Hayman et al., 2012) |
49 | Ghana | Jun 2007 | Oyibi | Epomophorus gambianus | Serology | (Hayman et al., 2012) |
50 | Ghana | Jan 2008 | Accra | Eidolon helvum | Serology | (Hayman et al., 2010) |
51 | Gabon | Mar 2008 | Near Franceville | Epomops franqueti | Serology | (Pourrut et al., 2009) |
ROC = Republic of Congo.
Predicted distribution of suspected reservoir species of bats
Three species of bats, Hypsignathus monstrosus, Myonycteris torquata and Epomops franqueti, were identified as the most likely candidates to be reservoir species for Ebola viruses due to high seroprevalence and the isolation of RNA closely related to Zaire ebolavirus (Leroy et al., 2005; Olival and Hayman, 2014). In total, 239 locations were identified from the Global Biodiversity Information Facility (GBIF) (GBIF, 2014): 67 for H. monstrosus (Figure 4A), 52 for M. torquata (Figure 4B) and 120 for E. franqueti (Figure 4C). Distribution models for all three species demonstrated predictive skill (indicated by an area under the curve (AUC) greater than 0.5) as follows: H. monstrosus AUC 0.63 ± 0.04; M. torquata AUC = 0.59 ± 0.04; E. franqueti AUC = 0.58 ± 0.03, n = 50 submodels for all three species. In addition, each species was broadly predicted within its considered expert opinion range (Figure 4A–C) (Schipper et al., 2008). The marginal effect plots (not shown) were strongly influenced by land surface temperature (LST) and vegetation (as measured by the enhanced vegetation index [EVI]). The predicted combined distribution of these species (Figure 4D), covers West and Central Africa, specifically the moist forests of the northeastern, western and central Congo basin, and Guinea, as well as the Congolian coastal forest ecoregions (WWF, 2014).
Predicted environmental suitability for zoonotic transmission of Ebola
The predicted environmental niche for zoonotic transmission of EVD is shown in Figure 5. All countries with observed index cases of EVD (n = 7, hereafter Set 1) have areas of the highest environmental suitability (see list in Table 1). In addition, areas of high environmental suitability for zoonotic transmission are predicted in a further 15 countries where, to date, index cases of the four African species of Ebolavirus have not been recorded. These are Nigeria, Cameroon, Central African Republic (CAR), Ghana, Liberia, Sierra Leone, Angola, Tanzania, Togo, Ethiopia, Mozambique, Burundi, Equatorial Guinea, Madagascar and Malawi (hereafter Set 2).
The AUC for the Ebola model was relatively high (AUC = 0.85 ± 0.04, n = 500 submodels) indicating that the model could strongly distinguish regions of environmental suitability for EVD. Enhanced vegetation index had the greatest impact on the distribution (relative contribution [RC] of 65.3%) followed by elevation (RC = 11.7%), night-time land surface temperature (LST) (RC = 7.7%), potential evapotranspiration (PET) (RC = 5.7%) and combined bat distribution (RC = 3.8%). Marginal effect plots are presented in Figure 5—figure supplement 2.
In total, 22.2 million people are predicted to live in areas suitable for zoonotic transmission of Ebola. The vast majority, 21.7 million (approximately 97%), live in rural areas, as opposed to urban or peri-urban areas (CIESIN/IFPRI/WB/CIAT, 2007; WorldPop, 2014). Of these, 15.2 million are in Set 1 and 7 million are in Set 2. In terms of ranked populations at risk, DRC, Guinea and Uganda are highest in Set 1 and Nigeria, Cameroon and CAR are top in Set 2. For a full listing of these populations living in areas of risk, see the stacked bar plot in Figure 5A.
National level demographic and mobility changes
Over the 40 year period since discovery of EVD, the total population living in those countries predicted to be within the zoonotic niche has nearly tripled (from 230 million to 639 million) and the proportion of the population in these countries living in an urban (rather than rural) setting has changed from 25.5% to 59.2% (Figure 6).
Figure 6. Changes in national population for countries predicted to contain areas at-risk of zoonotic Ebola virus transmission.
For each country the population (in millions) is presented for three time periods (1976, 2000 and 2014) as three bars. Each stacked bar gives the rural (green) and urban (blue) populations of the country. The grey rectangle highlights countries in which index cases of Ebola virus diseases have been reported (Set 1); the remainder are countries in which risk of zoonotic transmission is predicted, but where index cases have not been reported (Set 2). The fractional change in population between 1976 and 2014 is given above each set of bars.
Data on the connectivity of human populations over this period were not available. We can infer however, intuitively, empirically and theoretically (Zipf, 1946; Simini et al., 2012) that rates of population movement within a country will scale directly in proportion to population growth.
International connectivity by airline traffic
Records of passenger seat capacity are available since 2000 and show substantive increases over the period in Set 1 (from 2.96 to 4.77 million, a fractional change of 1.61) and Set 2 (from 5.6 to 15.6 million, a change of 2.8) (Figure 7A). More specific data on passenger volumes show almost universally similar increases since 2005 with Set 1 nations changing from 2 million to 2.5 million, a fractional change of 1.22 and Set 2 changing from 5 million to 7.9 million, a change of 1.57 (Figure 7B).
Figure 7. Changes in international flight capacity and traveller volumes for countries predicted to contain areas at-risk of zoonotic Ebola virus transmission.
The grey rectangle highlights countries in which index cases of EVD have been reported (Set 1). The remainder are countries in which risk of zoonotic transmission is predicted, but where index cases have not been reported (Set 2). (A) Shows changes in annual outbound international seat capacity (between 2000 in red and 2013 in blue). (B) Depicts changes in annual outbound international passenger volume by country (between 2005 in red and 2012 in blue). For each country, the fractional change in volume is given above each set of bars. Note that only one bar is presented for South Sudan as data for this region prior to formation of the country in 2011 were unavailable.
Global analysis of airline passenger volumes demonstrates that international connectivity has increased amongst all global regions and national income strata (Figure 8). Total passenger volumes have increased by a third from 9.5 to over 14 million during the eight year window (2005–2012) where records are available. The largest increases have occurred in WHO regions (WHO, 2014b) outside of the sub-Saharan African region (AFRO) (Figure 8A,B). In 2012, almost half of the final destinations of those travelling from these at-risk countries were to other AFRO nations (47%). Other frequent destinations were in Europe (EURO; 27%) and the Eastern Mediterranean (EMRO; 13%). Similarly, analysis of passenger volumes by World Bank national income groupings (WHO, 2014b) (Figure 8C,D) show that in 2012 40% of all passenger final destinations were to low or low-middle income countries.
Figure 8. Numbers of airline passengers arriving from at-risk countries to other countries stratified by major geographic regions and national income groups.
(A) Shows the locations of WHO regions (AFRO–African Region; AMRO–Region of the Americas; EMRO–Eastern Mediterranean Region; EURO–European Region; SEARO–South-East Asian Region; WPRO–Western Pacific Region). (B) Displays the numbers of passengers arriving in each of these regions from countries predicted to contain areas at risk of zoonotic Ebola virus transmission (Sets 1 and 2) in 2005 and 2012. (C) Shows the income tiers of all countries as defined by the World Bank. (D) Displays the total numbers of passengers arriving in countries in each of these income strata from at-risk countries in 2005 and 2012. The number above each pair of bars indicates the fractional change in these numbers of incoming passengers between 2005 and 2012.
Discussion
Summary of the main findings
We have re-evaluated the zoonotic niche for EVD in Africa. In doing so we have (i) used all existing outbreaks to assemble an inventory of index cases (n = 30); (ii) added to this all confirmed records of Ebola virus in animals (n = 51); (iii) assembled more accurate and contemporary environmental covariates including new maps of the distribution of confirmed OWFB reservoirs of the disease; and (iv) used the latest niche modelling techniques to predict the geographic distribution of potential zoonotic transmission of the disease. Using these predictions we have estimated the populations at risk of EVD both in countries which have confirmed index cases (Set 1, n = 7) and those for which we predict strong environmental suitability for outbreaks (Set 2, n = 15). In all countries at risk we show that since the discovery of EVD in 1976, urban and rural populations have increased and have become more interconnected both within and across national borders. During the last 40 years the increasing size and connectivity of these populations may have facilitated the subsequent spread of EVD outbreaks. These factors underline a change in the way in which EVD interacts with human populations.
Interpreting the zoonotic niche
The remote and isolated nature of Ebola zoonotic transmission events, paired with the relatively poor diagnostics and understanding of the disease transmission routes in early outbreaks, mean that under-reporting of previous outbreaks is probable. An increasing understanding and description of a broader range of symptoms used in case definitions of EVD (Leroy et al., 2000; Feldmann and Geisbert, 2011) also increase the possibility that past outbreaks may have been misattributed to different diseases (Tignor et al., 1993). This poor detectability of EVD also clearly limits capacity to accurately identify the locations and transmission routes of index cases (Heymann et al., 1980; Baize et al., 2014). We must assume, as has been done previously (Peterson et al., 2004a; Jones et al., 2008), that the first reported cases are representative of the true location of the index cases. Where possible we have represented this geographic uncertainty by attributing the index case to a wide-area polygon which then incorporated this uncertainty into the mapping process (see ‘Materials and methods’).
The relationship between the EVD niche and the environmental covariates (Figure 5—figure supplement 2), particularly the high relative contribution of the vegetation index, underscore that there are clear environmental limits to transmission of the virus from animals to humans, and that ecoregions dominated by rainforest are the primary home of such zoonotic cycles. Our analysis has shown that the zoonotic niche of the pathogen is more widespread than previously predicted or appreciated (Peterson et al., 2004a), most notably in West Africa.
This analysis used information from all human outbreaks and animal infections to delineate the likely zoonotic niche of the disease. Further analysis, excluding the existing outbreak focussed in Guinea from the dataset used to train the model (Figure 5—figure supplement 3), still resulted in prediction of high suitability in this region, with the presumed index village located within 5 km of an at-risk pixel. This implies that the eco-epidemiological situation in Guinea is very similar to that in past outbreaks, mirroring phylogenetic similarity in the causative viruses (Dudas and Rambaut, 2014; Gire et al., 2014). The ecological similarity between the past and current outbreaks also lends support to the notion that the scale of this outbreak is more heavily influenced by patterns of human-to-human transmission than any expansion of the zoonotic niche.
Interpreting population at risk
It is important to appreciate that this zoonotic niche map delineates areas in which populations are at-risk of zoonotic transmission of EVD (Figure 5B). It does not predict the likelihood of EVD spillover, the likelihood of an outbreak establishing, or its subsequent rate of spread within a population. Increasing human encroachment and certain cultural practices sometimes linked with poverty, such as bushmeat hunting, result in increasing exposure of humans to animals which may harbour diseases including Ebola (Daszak, 2000; Wolfe et al., 2005, 2007). Increasing human population may accelerate the degree of risk through these processes but spatially refined information on these factors is not available comprehensively. It is hoped that as the understanding of the risk factors for zoonotic transmission of Ebolavirus to humans increases, it will be possible to incorporate this information into future risk mapping assessments.
Previous considerations of the geographic distribution of EVD have used human outbreaks alone. We have updated this work to include the last decade of outbreaks, as well as disaggregated outbreaks where evidence suggests multiple independent zoonotic transmission events overlap in space and time. Furthermore, our modelling process accommodates uncertainty in geopositioning of these index cases by utilising both point and polygon data. In addition, we include occurrence of infection in wildlife, important to the wider scale of zoonotic transmission (Figure 1), which in total has increased the dataset used in the model to 81 occurrences. The rareness of EVD outbreaks and the prevalence of detectable Ebola virus in reservoir species suggests that there will always be a limited set of observation data when compared to mapping of more prevalent zoonoses (Pigott et al., 2014). The results demonstrate predictive skill using a stringent validation procedure, however, indicating strong model performance even with this relatively limited observation dataset.
A broad zoonotic niche is predicted across 22 countries in Central and West Africa. Whilst several of these countries have reported index cases of EVD, others have not, although serological evidence in some regions points to possible underreporting of small-scale outbreaks (Kuhn, 2008). With improved ecological understanding, particularly with improvements to our knowledge of specific reservoir species and their distributions, it may be possible to delineate areas not at risk due to the absence of these species.
Despite relatively a large population living in areas of risk and the widespread practice of bushmeat hunting in these predicted areas (Wolfe et al., 2005; Mfunda and Røskaft, 2010; Brashares et al., 2011; Kamins et al., 2011), Ebolavirus is rare both in suspected animal reservoirs (Leroy et al., 2005; Olival and Hayman, 2014) and in terms of human outbreaks (Table 1). There is some indication however, that the frequency of Ebola outbreaks has increased since 2000, as shown in Figure 2A. We have shown that the human population living within this niche is larger, more mobile and better internationally connected than when the pathogen was first observed. As a result, when spillover events do occur, the likelihood of continued spread amongst the human population is greater, particularly in areas with poor healthcare infrastructure (Briand et al., 2014; Fauci, 2014).
Whilst rare in comparison to other high burden diseases prevalent in this region, such as malaria (Gething et al., 2011; Murray et al., 2012), Ebola outbreaks can have a considerable economic and political impact, and the subsequent destabilisation of basic health care provisioning in affected regions increases the toll of unrecorded morbidity and mortality of more common infectious diseases (Murray et al., 2014; Wang et al., 2014), throughout and after the epidemic period. The number of concurrent infections during the present outbreak represents a significant strain on healthcare systems that are already poorly provisioned (Briand et al., 2014; Chan, 2014; Fauci, 2014) and many other Set 1 and Set 2 countries rank amongst the lowest per capita healthcare spenders. These considerations should be paramount when international organizations debate the financing requirements for the improvement of healthcare needed in the region and the urgency with which new therapeutics and vaccines can be brought into production (Brady et al., 2014; Goodman, 2014).
Together, these considerations necessitate prioritisation of efforts to reinforce and improve existing surveillance and control, and encourage the development of therapeutics and vaccines. The national population at risk estimates presented here would be a strong rationale for improving, prioritising and stratifying surveillance for EVD outbreaks and diagnostic capacity in these countries. We believe it would be prudent to test OWFB species in Set 2 countries for Ebola virus (Hayman et al., 2012), particularly during the bat breeding season to maximise chances of isolation in order to clarify the outbreak risk in these countries. In all Set 1 and Set 2 countries, raising awareness about the risk presented by reservoir bats and incidental primate hosts and the modes of transmission of this disease could be of value. Finally, increasing our capacity to rapidly map ever changing biological threats is also a core need (Hay et al., 2013b).
Interpreting International connectivity
The increasing connectedness of the Africa region means that EVD is now a problem of international concern. While most EVD secondary transmission occurs locally and is likely transported via ground transit (Francesconi et al., 2003), the potential for international spread of infection is possible, as demonstrated by the importation of the disease from Liberia to Nigeria, culminating in further secondary transmission in Lagos (WHO, 2014a). The aetiology of EVD infection and disease progression means that an international outbreak propagated by air travel remains unlikely, particularly in high-income countries better able to handle EVD cases (Fauci, 2014). Nevertheless, a non-negligible threat remains, particularly in the low and middle income destinations and the rapid increase in global connectivity of these at-risk regions indicates that international airports could see more imported cases (Chan, 2014).
Future work
We have focussed on reanalysing the zoonotic niche for EVD transmission and the characterisation of the populations at risk to improve the landscape in which future risk and impact of EVD outbreaks can be discussed. During the current emergency much of the work will concentrate on routes of secondary transmission in the human population—conceptually the red arrow of the H box in Figure 1. An important task is to stratify the risk of EVD spread both within and between countries and identify the most likely pathways of spread for characterisation and surveillance. Our next priority therefore is to investigate aspects of secondary human-to-human transmission by documenting the rate of geographic spread of EVD during the past and ongoing epidemics to help understand changes in these patterns in the historical record. Simulating these movements in a real landscape of population movement patterns, inferred from population movements assessed by mobile phones and other data (Garcia et al., 2014), as well as parametric movement models (Simini et al., 2013) is a logical next step, and can be used in future targeting of interventions and potential new treatments for both the current and future outbreaks (Brady et al., 2014; Goodman, 2014).
As previously discussed, whilst there is the risk of human travel during the latent phase of infection, and therefore potential for international spread, the high pathogenicity during infectiousness (immobilising infected persons) and the likely rapid and effective isolation measures implemented in regions with strong health care systems, limit the pandemic potential of EVD. Nevertheless, improvement of international containment plans and informed discussions of potential risks to airline carriers and populations of other regions will be supported by knowledge of local, regional and international population flows. Assessing these flows by air traffic volumes is an ongoing priority.
There are several other zoonotic viral haemorrhagic fevers (for example Marburgvirus, Lassa fever, hantaviral infections and arenaviruses) that are of similar public health and biosecurity concern (Bannister, 2010), due to their high virulence and mortality and their potential to cause outbreaks and spread internationally. Despite this their geographical distributions are poorly understood (Hay et al., 2013a). Many of the methods applied here can be adapted to these diseases and improve our geographical understanding of the risk presented by these pathogens.
We are in the midst of a public health emergency that will likely last for many more months (Chan, 2014) and which has brought EVD to global attention. We emphasise that the maps of zoonotic transmission presented here do not enable assessment of secondary transmission rates in human populations, but they do act as an evidenced-based indicator of locations with potential for future zoonotic transmission and thus outbreaks. Interestingly, early reports of another independent zoonotic outbreak in the DRC (MSF, 2014) are in predicted at-risk areas. An improved understanding of the spatial extent of the zoonotic niche can only help future efforts in biosurveillance.
Materials and methods
Methodological overview
A boosted regression tree (BRT) modelling framework was used to generate predictive risk maps of the zoonotic Ebola virus niche in Africa. This methodology combines regression trees, where trees are built according to optimal decision rules based on how binary decisions best accommodate a given dataset (De'ath, 2007; Elith et al., 2008), and boosting, which selects the tree that minimises the loss function. In doing so, a parameter space is defined which captures the greatest amount of variation present in the dataset. In order to train the model, four component datasets were compiled: (i) a comprehensive dataset of the reported locations of Ebola virus transmission from a zoonotic reservoir to a human; (ii) a dataset of the locations of Ebola virus infections in suspected reservoir and (non-human) susceptible host species (iii) a suite of ecologically relevant environmental covariates for Africa, including predicted distribution maps of suspected reservoir bat species and (iv) background (or pseudo-absence) records representing locations where zoonotic Ebola virus has not been reported. This study was limited to the African continent since no natural outbreaks of EVD have occurred outside the continent (CDC, 2014). Only Reston ebolavirus has a distribution reported outside of Africa, focussed in the Philippines, but has never been reported as pathogenic in humans; as a result this species was not included in the analysis.
Identifying index cases and reconstructing zoonotic transmission events in space and time
Tables detailing proven outbreaks of Ebola virus, initially sourced from the scientific literature (Kuhn, 2008) and from health reporting organisations (CDC, 2014), were used to coordinate searches of the formal scientific literature using Web of Science and PubMed for each specific outbreak. Relevant papers were abstracted and where possible outbreak-specific epidemiological surveys were sourced. The citations in these references were obtained in order to reconstruct the outbreak in detail and to identify the most probable index case. Index cases were defined as any human infection resulting from interaction with non-human sources of the disease. Some of these cases arose from presumed interactions with zoonotic reservoirs or hosts, such as primates and other mammals during hunting trips (Boumandouki et al., 2005; Nkoghe et al., 2005, 2011; WHO, 2003) or butchering of bats (Leroy et al., 2009). Any cases arising from existing human infections are considered as secondary infections rather than index cases. Similar to methodology employed elsewhere (Messina et al., 2014), the site, or supposed site, of this zoonotic transmission event was geopositioned using Google Earth. For locations where precise geographic information (e.g., geographic coordinates of a hunting camp) was provided by the authors, these were used. Where precise geographic information could not be accurately geopositioned, a geographic area (termed a polygon) was defined covering the reported region. In several cases only the first reported patient could be identified, with the source of infection unknown. With these outbreaks the location of the first patient was geopositioned under the assumption that an initial zoonotic spillover event occurred in the vicinity of this location. In two outbreaks multiple independent zoonotic transmission events were identified (WHO, 2003; Nkoghe et al., 2005; Pourrut et al., 2005), and each unique event was geopositioned and included in the model as separate entities. Table 1 catalogues the outbreaks used in this study.
Assembling a database of reported infections in animals
A literature search was conducted in Web of Science using the search term “Ebola” that returned 8635 citations. The abstracts were examined and for those that contained possible data on animal Ebola infection, the full text was obtained. The sampling site or location of the animal in the study was identified and geopositioned using Google Maps. These locations were recorded either as precise locations or as polygons, as with human index cases. Records for which local transmission of Ebola virus was deemed unlikely (e.g., seropositive primates tested in containment facilities several years after their capture) were excluded from the study. The non-human Ebola virus occurrence data collected are detailed in Table 2, including the diagnostic methods used.
GenBank isolates
The open access sequence database GenBank (NCBI, 2014) was searched using MESH Umbrella search terms for Ebola virus, returning 181 results. These were then manually cross-referenced with the existing human and animal Ebola information, collected above, and 30 duplicates were removed. For the remaining isolates, original references and GenBank information fields were examined, but as there was insufficient information to establish precise location of isolation and/or whether the isolate represented an index case for any of these data sources, they were excluded from subsequent analyses.
Covariates assembled and used in the analyses
A suite of ecologically relevant gridded environmental covariates for Africa was compiled, each having a nominal resolution of 5 km × 5 km. The environmental covariates used in this analysis were: elevation (from the shuttle radar topography mission [ORNL DAAC, 2000]); the mean value, and a measure of spatial variation (range, described below) between 2000 and 2012 of Enhanced Vegetation Index (EVI), daytime Land Surface Temperature (LST) and night-time LST; and mean potential evapotranspiration from 1950–2000 (Trabucco and Zomer, 2009) (Figure 5—figure supplement 1).
The EVI and LST datasets were derived from satellite imagery collected by NASA's Moderate Resolution Imaging Spectroradiometer (MODIS) remote sensing platform (Tatem et al., 2004). EVI is a metric designed to characterise vegetation density and vigour based on the ratio of absorbed photosynthetically active radiation to near infrared radiation (Huete et al., 2002). LST is a modelled product derived from emissivity as measured by the MODIS thermal sensor (Wan and Li, 1997), which is correlated, though not synonymous with air temperature, and effective for differentiating landscapes based on a combination of thermal energy and properties of surface types. The MODIS datasets utilized in this research (EVI was derived from the MCD43B4 product and the MOD11A2 LST product was used directly) were acquired as composite datasets created using imagery collected over multiple days, a procedure that results in products with 8-day temporal resolutions. Despite compositing, the EVI and LST datasets contained gaps due to persistent cloud cover found in forested equatorial regions, and these gaps were filled using a previously described approach (Weiss et al., 2014a). The EVI and LST datasets were then aggregated from their native 1 km × 1 km spatial resolution to a final 5 km × 5 km resolution, calculating both the mean and the range of the values of the subpixels making up each larger pixel. These spatial summaries therefore characterise both the mean temperature in each location as well as the degree of spatial heterogeneity within that pixel. This is of interest as humans and susceptible species are more likely to come into contact in transitional areas (e.g., boundary areas between areas of highly suitable susceptible species habitat and areas heavily utilised by humans). The final covariate production step consisted of summarising temporally across the 13-year data archive to produce synoptic datasets devoid of annual or seasonal anomalies (Weiss et al., 2014a).
Implicated bat reservoir distributions
Over recent years, significant research has been undertaken in investigating the role bats have to play in the transmission cycle of Ebola viruses (Olival and Hayman, 2014) and evidence of asymptomatic infection in fruit bats has been documented to varying extents (Leroy et al., 2005; Pourrut et al., 2007, 2009; Hayman et al., 2010; Hayman et al., 2012). In order to incorporate this potential driver of Ebola virus transmission into the model we developed predicted distribution maps for three species of fruit bat implicated as primary reservoirs of the disease: Hypsignathus monstrosus, Epomops franqueti and Myonycteris torquata. The evidence was strongest for these three species having a reservoir role as Ebola virus RNA (all nested within the Zaire ebolavirus phylogeny [Leroy et al., 2005]) has been detected in all three. Whilst a handful of other bat species have been found to be seropositive, no further viral isolations have been recorded (Olival and Hayman, 2014).
Whilst expert opinion range maps for these species exist (Schipper et al., 2008), there is some disagreement with independently-sourced occurrence data (all archived in the Global Biodiversity Information Facility). As a result, a predictive modelling approach was used to create a continuous surface of habitat suitability for these species which we then included as a predictor in the model. Occurrence data for all Megachiroptera in Africa was extracted from GBIF (GBIF, 2014) using the R packages dismo (Hijmans et al., 2014) and taxize (Chamberlain et al., 2014). To remove apparently erroneous records in the GBIF archive all occurrence records more than 100 km from the species known ranges, as determined by expert-opinion range maps (Schipper et al., 2008), were excluded, as were duplicate records and those located in the ocean. This resulted in a total dataset of 1341 unique occurrence records.
The occurrence database was then used to train separate boosted regression tree species distribution models (Elith et al., 2008) to predict the likely distribution of each of these suspected reservoir species. For each model, occurrence records for the target species (H. monstrosus, n = 67; E. franqueti, n = 120; and M. torquata, n = 52) were considered presence records and occurrence records of all other species were used as background records. This procedure is designed to account for the potentially biasing effect of spatial variation in recording of Megachiroptera occurrences (Phillips et al., 2009).
For each species we ran fifty submodels each trained to a randomly selected bootstrap of this dataset, subject to the constraint that each bootstrap contained a minimum of 10 occurrence and 10 background records. Each submodel was fitted using the gbm.step subroutine (Elith et al., 2008) in the dismo R package. In each submodel the background records were down weighted so that the weighted sum of presence records equalled the weighted sum of background records (Barbet-Massin et al., 2012) in order to maximise the discrimination capacity of the model. We generated a prediction map from each of these submodels and calculated both the mean prediction and 95% confidence interval around the prediction for each 5 km × 5 km pixel for each species.
Model accuracy was assessed by calculating the mean area under the curve (AUC) statistic for each submodel under a stringent 10-fold cross validation for each submodel and obtaining the mean and standard deviation across all 50 submodels. Under this procedure the dataset was split into ten subsets, each containing approximately equal numbers of presence and background points. The ability of a model trained on each subset to predict the distribution of the other 90% of records was assessed by AUC and the mean value taken. As so few presence records were used to train each fold model (i.e., around 5 presence records for M. torquata up to 12 for E. franqueti), this represents a very stringent test of the model's predictive capacity. Additionally, to prevent inflation of the accuracy statistics due to spatial sorting bias, these statistics were estimated using a pairwise distance sampling procedure (Hijmans, 2012). Consequently, the AUC statistics presented here are lower than would be returned by standard procedures but gives a more realistic quantification of the model's ability to extrapolate predictions to new regions (Wenger and Olden, 2012). We also generated marginal effect plots with associated uncertainty intervals and relative contribution statistics (how often each covariate was selected during the model fitting process) as quantification of the sensitivity of the model to the different covariates. These allow us to make inferences about the ecological relationship between each species and its environment as well as to identify where this relationship is most uncertain.
To generate a single surface describing the distribution of the bat reservoir species to be used as a covariate in the subsequent Ebola modelling, the three mean prediction distribution maps were merged by taking the average habitat suitability for each of the three bat species at each pixel.
Ebola distribution modelling
The Ebola virus occurrence dataset was supplemented with a background record dataset generated by randomly sampling 10,000 locations across Africa, biased towards more populous areas as a proxy for reporting bias (Phillips et al., 2009). We fitted 500 submodels to bootstraps of this dataset. To account for uncertainty in the geographic location of those occurrences reported as polygons, for each submodel one point was randomly selected from each of these occurrence polygons. This Monte Carlo procedure enabled the model to efficiently integrate over the environmental uncertainty associated with imprecise geographic data. A bootstrap sample was then taken from each of these datasets and used to train the BRT model using the same procedure and weighting of background records as for the bat distribution models. Similarly, we generated a prediction map from each of these models and calculated both the mean prediction and corresponding 95% confidence intervals for each pixel and analysed prediction accuracy using the same stringent cross validation and sensitivity analysis procedure as for the bat distribution models (detailed above).
The predicted distribution map produced by this approach represents the environmental suitability of each pixel for zoonotic Ebola virus transmission. This may be interpreted as a relative probability of presence in the sense that more suitable pixels are more likely to contain zoonotic transmission than less suitable pixels, though not an absolute probability that transmission occurs in a given pixel. Similarly, the presence of zoonotic transmission increases the risk of transmission to a human, though this is also contingent on how humans interact with these zoonotic pools, through hunting or other activities.
Population living in areas of environmental suitability for zoonotic transmission
In order to identify areas which are likely to be at risk of transmission of Ebolavirus from zoonotic reservoir hosts to humans, the continuous map of the predicted environmental suitability for zoonotic transmission (shown in Figure 5) was converted into a binary map classifying pixels as either at risk or not at risk. A pixel was assumed to be at risk if its predicted environmental suitability for zoonotic Ebola virus transmission was greater than 0.673, the lowest suitability value predicted at the locations of known transmission to humans (point records of human index cases). Countries containing at least one at-risk pixel are shown in Figure 5B—those countries that previously report an index case were defined as Set 1; countries with at least one at-risk pixel with no previous index cases of EVD were categorised as Set 2. The number of people living in at-risk areas in each of these countries was calculated by summing the estimated population of at-risk pixels using population density maps from the AfriPop project (Linard et al., 2012; WorldPop, 2014) and the proportion of those living in urban, periurban and rural areas was evaluated using the Global Rural Urban Mapping Project (CIESIN/IFPRI/WB/CIAT, 2007).
The R code used for all of the analysis has been made available on an open source basis (https://github.com/SEEG-Oxford/ebola_zoonotic).
National level demographic and mobility data
For three separate years (1976, 2000 and 2014), total national populations were retrieved and the proportion of rural to urban populations noted from World Bank statistics (World Bank, 2014). To describe global air travel patterns from Set 1 and Set 2 countries, flight schedules data from the Official Airline Guide, reflecting an estimated 95% of all commercial flights worldwide, were analysed between 2000 and 2013 to calculate the annual volume of seats on direct flights that depart from each predicted country and which have an international destination. Complementing these seat capacity data, worldwide data on anonymised, individual passenger flight itineraries from the International Air Transport Association (2012) (IATA, 2014) were analysed between 2005 and 2012 to calculate the annual volume of international passenger departures out of each Set 1 and Set 2 country. The IATA dataset represents an estimated 93% of the world's commercial air traffic at the passenger level and includes points of departure and arrival and final destination information for travellers as well as their connecting flights.
Acknowledgements
We thank Katherine Battle, Maria Devine and Kirsten Duda for proof-reading and Jane Messina for creating Figure 1. We also thank Andrew Rambaut for his comments on the final draft.
Funding Statement
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Funding Information
This paper was supported by the following grants:
University Of Oxford FundRef identification ID: http://dx.doi.org/10.13039/501100000769 Sir Richard Southwood Graduate Scholarship to David M Pigott.
Bill and Melinda Gates Foundation FundRef identification ID: http://dx.doi.org/10.13039/100000865 OPP1053338 to Nick Golding.
Medical Research Council FundRef identification ID: http://dx.doi.org/10.13039/501100000265 K00669X to Peter W Gething.
Biotechnology and Biological Sciences Research Council FundRef identification ID: http://dx.doi.org/10.13039/501100000268 Studentship to Oliver J Brady.
German Academic Exchange Service FundRef identification ID: http://dx.doi.org/10.13039/501100001655 Graduate Scholarship to Moritz UG Kraemer.
U.S. National Library of Medicine FundRef identification ID: http://dx.doi.org/10.13039/100000092 R01LM010812 to John S Brownstein, Sumiko R Mekaru.
7th Framework Programme for Research and Technological Development (EU FP7) 602525 to Peter W Horby.
Canadian Institutes of Health Research FundRef identification ID: http://dx.doi.org/10.13039/501100000024 to Isaac I Bogoch, Kamran Khan.
Wellcome Trust FundRef identification ID: http://dx.doi.org/10.13039/100004440 095066 to Adrian Mylne, Simon I Hay.
RAPIDD program of the Science & Technology Directorate to Andrew J Tatem, Simon I Hay.
Fogarty International Center FundRef identification ID: http://dx.doi.org/10.13039/100000061 to Andrew J Tatem, Simon I Hay.
Bill and Melinda Gates Foundation FundRef identification ID: http://dx.doi.org/10.13039/100000865 OPP1106023 to Zhi Huang, Andrew J Henry, Catherine L Moyes.
Bill and Melinda Gates Foundation FundRef identification ID: http://dx.doi.org/10.13039/100000865 OPP1068048 to Daniel J Weiss, Samir Bhatt.
Bill and Melinda Gates Foundation FundRef identification ID: http://dx.doi.org/10.13039/100000865 OPP1093011 to Catherine L Moyes, John S Brownstein, Sumiko R Mekaru, Simon I Hay.
National Institute of Allergy and Infectious Diseases FundRef identification ID: http://dx.doi.org/10.13039/100000060 U19AI089674 to Andrew J Tatem.
Bill and Melinda Gates Foundation FundRef identification ID: http://dx.doi.org/10.13039/100000865 OPP1106427 to Andrew J Tatem.
Bill and Melinda Gates Foundation FundRef identification ID: http://dx.doi.org/10.13039/100000865 OPP1032350 to Andrew J Tatem.
Additional information
Competing interests
SIH: Reviewing editor, eLife.
The other authors declare that no competing interests exist.
Author contributions
DMP, Advised and assembled the outbreak and animal infection data, Wrote the article.
NG, Extracted the bat data, Conducted all of the analysis, Drafting or revising the article.
AM, Assembled and geo-positioned the outbreak and animal infection data, Drafting or revising the article.
ZH, Geo-positioned the outbreak and animal infection data, Provided all maps, Drafting or revising the article.
AJH, Analysed international flight data, Helped assemble maps, Drafting or revising the article.
IIB, Assisted with international transportation analysis, Edited the final draft of the article.
SRM, Assisted in geopositioning, Drafting or revising the article.
AJT, Provided information on urban change and migration data, Drafting or revising the article.
KK, Provided data, Conducted all analyses on international air traffic patterns, Drafting or revising the article.
DJW, Assembled the covariate layers, Drafting or revising the article.
SB, Extracted Ebola information from GenBank, Drafting or revising the article.
OJB, Screened GenBank data, Provided Figure 2A, Drafting or revising the article.
MUGK, Analysis and interpretation of data, Drafting or revising the article.
DLS, Analysis and interpretation of data, Drafting or revising the article.
CLM, Analysis and interpretation of data, Drafting or revising the article.
PWG, Assembled the covariate layers, Drafting or revising the article.
PWH, Advised on international public health context, Edited the final draft of the article.
JSB, Advised on international public health context, Edited the final draft of the article.
SIH, Conceived the work and analysis, Wrote content and edited the article at all stages of development, Acts as guarantor of the paper.
References
- Amblard J, Obiang P, Edzang S, Prehaud C, Bouloy M, Guenno BL. 1997. Identification of the Ebola virus in Gabon in 1994. Lancet 349:181–182. doi: 10.1016/S0140-6736(05)60984-1 [DOI] [PubMed] [Google Scholar]
- Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keïta S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traoré A, Kolié M, Malano ER, Heleze E, Bocquin A, Mély S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, Günther S. 2014. Emergence of Zaire Ebola virus disease in Guinea - preliminary report. The New England Journal of Medicine doi: 10.1056/NEJMoa1404505 [DOI] [PubMed] [Google Scholar]
- Bannister B. 2010. Viral haemorrhagic fevers imported into non-endemic countries: risk assessment and management. British Medical Bulletin 95:193–225. doi: 10.1093/Bmb/Ldq022 [DOI] [PubMed] [Google Scholar]
- Barbet-Massin M, Jiguet F, Albert CH, Thuiller W. 2012. Selecting pseudo-absences for species distribution models: how, where and how many? Methods in Ecology and Evolution 3:327–338. doi: 10.1111/j.2041-210X.2011.00172.x [DOI] [Google Scholar]
- Baron RC, McCormick JB, Zubeir OA. 1983. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bulletin of the World Health Organization 61:997–1003 [PMC free article] [PubMed] [Google Scholar]
- Barrette RW, Metwally SA, Rowland JM, Xu LZ, Zaki SR, Nichol ST, Rollin PE, Towner JS, Shieh WJ, Batten B, Sealy TK, Carrillo C, Moran KE, Bracht AJ, Mayr GA, Sirios-Cruz M, Catbagan DP, Lautner EA, Ksiazek TG, White WR, McIntosh MT. 2009. Discovery of swine as a host for the Reston ebolavirus. Science 325:204–206. doi: 10.1126/science.1172705 [DOI] [PubMed] [Google Scholar]
- Bausch DG, Schwarz L. 2014. Outbreak of Ebola virus disease in Guinea: where ecology meets economy. PLOS Neglected Tropical Diseases 8:e3056. doi: 10.1371/journal.pntd.0003056 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beer B, Kurth R, Bukreyev A. 1999. Characteristics of Filoviridae: Marburg and Ebola viruses. Die Naturwissenschaften 86:8–17. doi: 10.1007/s001140050562 [DOI] [PubMed] [Google Scholar]
- Bermejo M, Rodríguez-Teijeiro JD, Illera G, Barroso A, Vilà C, Walsh PD. 2006. Ebola outbreak killed 5000 gorillas. Science 314:1564. doi: 10.1126/science.1133105 [DOI] [PubMed] [Google Scholar]
- Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI. 2013. The global distribution and burden of dengue. Nature 496:504–507. doi: 10.1038/Nature12060 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boumandouki P, Formenty P, Epelboin A, Campbell P, Atsangandoko C, Allarangar Y, Leroy EM, Kone ML, Molamou A, Dinga-Longa O, Salemo A, Kounkou RY, Mombouli V, Ibara JR, Gaturuku P, Nkunku S, Lucht A, Feldmann H. 2005. [Clinical management of patients and deceased during the Ebola outbreak from October to December 2003 in Republic of Congo]. Bulletin de la Société de Pathologie Exotique 98:218–223 [PubMed] [Google Scholar]
- Brady OJ, Hay SI, Horby P. 2014. Estimating vaccine and drug requirements for Ebola outbreaks. Nature 512:7514. doi: 10.1038/512233a [DOI] [Google Scholar]
- Brashares JS, Golden CD, Weinbaum KZ, Barrett CB, Okello GV. 2011. Economic and geographic drivers of wildlife consumption in rural Africa. Proceedings of the National Academy of Sciences of USA 108:13931–13936. doi: 10.1073/pnas.1011526108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Briand S, Bertherat E, Cox P, Formenty P, Kieny MP, Myhre JK, Roth C, Shindo N, Dye C. 2014. The international Ebola emergency. The New England Journal of Medicine doi: 10.1056/NEJMp1409858 [DOI] [PubMed] [Google Scholar]
- Brockmann D, Helbing D. 2013. The hidden geometry of complex, network-driven contagion phenomena. Science 342:1337–1342. doi: 10.1126/science.1245200 [DOI] [PubMed] [Google Scholar]
- Caillaud D, Levréro F, Cristescu R, Gatti S, Dewas M, Douadi M, Gautier-Hion A, Raymond M, Ménard N. 2006. Gorilla susceptibility to Ebola virus: the cost of sociality. Current Biology 16:R489–R491. doi: 10.1016/j.cub.2006.06.017 [DOI] [PubMed] [Google Scholar]
- CDC 2014. Chronology of Ebola hemorrhagic fever outbreaks. Accessed: August 2014. Available: http://www.cdc.gov/vhf/ebola/resources/outbreak-table.html
- Chamberlain S, Szocs E, Boettiger C, Ram K, Bartomeus I, Baumgartner J. 2014. taxize: taxonomic information from around the web. R package. Accessed: August 2014. Available: https://github.com/ropensci/taxize [Google Scholar]
- Chan M. 2014. Ebola virus disease in West Africa - no early end to the outbreak. The New England Journal of Medicine online. doi: 10.156/NEJMp1409859 [DOI] [PubMed] [Google Scholar]
- Chowell G, Hengartner NW, Castillo-Chavez C, Fenimore PW, Hyman JM. 2004. The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. Journal of Theoretical Biology 229:119–126. doi: 10.1016/j.jtbi.2004.03.006 [DOI] [PubMed] [Google Scholar]
- CIESIN/IFPRI/WB/CIAT 2007. Global Rural Urban Mapping Project (GRUMP): gridded population of the world, version 3. Accessed: December 2013. Available: http://sedac.ciesin.columbia.edu/gpw
- Cohen B. 2004. Urban growth in developing countries: a review of current trends and a caution regarding existing forecasts. World Development 32:23–51. doi: 10.1016/j.worlddev.2003.04.008 [DOI] [Google Scholar]
- Conrad JL, Isaacson M, Smith EB, Wulff H, Crees M, Geldenhuys P, Johnston J. 1978. Epidemiologic investigation of Marburg virus disease, Southern Africa, 1975. The American Journal of Tropical Medicine and Hygiene 27:1210–1215 [DOI] [PubMed] [Google Scholar]
- Daszak P. 2000. Emerging infectious diseases of wildlife - threats to biodiversity and human health. Science 287:443–449. doi: 10.1126/science.287.5452.443 [DOI] [PubMed] [Google Scholar]
- De'ath G. 2007. Boosted trees for ecological modeling and prediction. Ecology 88:243–251. doi: 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2 [DOI] [PubMed] [Google Scholar]
- Dudas G, Rambaut A. 2014. Phylogenetic analysis of Guinea 2014 EBOV ebolavirus outbreak. PLOS Currents 6:ecurrents.outbreaks.84eefe85ce43ec89dc80bf0670f0677b0678b0417d. doi: 10.1371/currents.outbreaks.84eefe5ce43ec9dc0bf0670f7b8b417d [DOI] [PMC free article] [PubMed] [Google Scholar]
- ECDC 2014. Outbreak of Ebola virus disease in West Africa. Stockholm: ECDC; p. 17 [Google Scholar]
- Elith J, Leathwick JR. 2009. Species distribution models: ecological explanation and prediction across space and time. Annual Review of Ecology, Evolution, and Systematics 40:677–697. doi: 10.1146/annurev.ecolsys.110308.120159 [DOI] [Google Scholar]
- Elith J, Leathwick JR, Hastie T. 2008. A working guide to boosted regression trees. The Journal of Animal Ecology 77:802–813. doi: 10.1111/j.1365-2656.2008.01390.x [DOI] [PubMed] [Google Scholar]
- Fauci AS. 2014. Ebola - underscoring the global disparities in health care resources. The New England Journal of Medicine doi: 10.1056/NEJMp1409494 [DOI] [PubMed] [Google Scholar]
- Feldmann H, Geisbert TW. 2011. Ebola haemorrhagic fever. Lancet 377:849–862. doi: 10.1016/S0140-6736(10)60667-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Formenty P, Boesch C, Wyers M, Steiner C, Donati F, Dind F, Walker F, Le Guenno B. 1999. Ebola virus outbreak among wild chimpanzees living in a rain forest of Cote d'Ivoire. The Journal of Infectious Diseases 179(suppl 1):S120–S126. doi: 10.1086/514296 [DOI] [PubMed] [Google Scholar]
- Francesconi P, Yoti Z, Declich S, Onek PA, Fabiani M, Olango J, Andraghetti R, Rollin PE, Opira C, Greco D, Salmaso S. 2003. Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerging Infectious Diseases 9:1430–1437. doi: 10.3201/eid0911.030339 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Franklin J. 2009. Mapping species distributions. Cambridge: Cambridge University Press; p. 320 [Google Scholar]
- Garcia AJ, Pindolia DK, Lopiano KK, Tatem AJ. 2014. Modeling internal migration flows in sub-Saharan Africa using census microdata. Migration Studies in press. doi: 10.1093/migration/mnu036 [DOI] [Google Scholar]
- GBIF 2014. Global biodiversity information facility. Accessed: August 2014. Available: http://www.gbif.org/
- Gear JS, Cassel GA, Gear AJ, Trappler B, Clausen L, Meyers AM, Kew MC, Bothwell TH, Sher R, Miller GB, Schneider J, Koornhof HJ, Gomperts ED, Isaäcson M, Gear JH. 1975. Outbreake of Marburg virus disease in Johannesburg. British Medical Journal 4:489–493. doi: 10.1136/bmj.4.5995.489 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Georges AJ, Leroy EM, Renaut AA, Benissan CT, Nabias RJ, Ngoc MT, Obiang PI, Lepage JP, Bertherat EJ, Bénoni DD, Wickings EJ, Amblard JP, Lansoud-Soukate JM, Milleliri JM, Baize S, Georges-Courbot MC. 1999. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. The Journal of Infectious Diseases 179:S65–S75. doi: 10.1086/514290 [DOI] [PubMed] [Google Scholar]
- Georges-Courbot MC, Sanchez A, Lu CY, Baize S, Leroy E, Lansout-Soukate J, Tévi-Bénissan C, Georges AJ, Trappier SG, Zaki SR, Swanepoel R, Leman PA, Rollin PE, Peters CJ, Nichol ST, Ksiazek TG. 1997. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerging Infectious Diseases 3:59–62. doi: 10.3201/eid0301.970107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IR, Johnston GL, Tatem AJ, Hay SI. 2011. A new world malaria map: Plasmodium falciparum endemicity in 2010. Malaria Journal 10:378. doi: 10.1186/1475-2875-10-378 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gilbert M, Golding N, Zhou H, Wint GR, Robinson TP, Tatem AJ, Lai S, Zhou S, Jiang H, Guo D, Huang Z, Messina JP, Xiao X, Linard C, Van Boeckel TP, Martin V, Bhatt S, Gething PW, Farrar JJ, Hay SI, Yu H. 2014. Predicting the risk of avian influenza A H7N9 infection in live-poultry markets across Asia. Nature Communications 5:4116. doi: 10.1038/ncomms5116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gire SK, Goba A, Andersen KG, Sealfon RSG, Park DJ, Kanneh L, Jalloh S, Momoh M, Fullah M, Dudas G, Wohl S, Moses LM, Yozwiak NL, Winnicki S, Matranga CB, Malboeuf CM, Qu J, Gladden AD, Schaffner SF, Yang X, Jiang PP, Nekoui M, Colubri A, Coomber MR, Fonnie M, Moigboi A, Gbakie M, Kamara FK, Tucker V, Konuwa E, Saffa S, Sellu J, Jalloh AA, Kovoma A, Koninga J, Mustapha I, Kargbo K, Foday M, Yillah M, Kanneh F, Robert W, Massally JLB, Chapman SB, Bochicchio J, Murphy C, Nusbaum C, Young S, Birren BW, Grant DS, Scheiffelin JS, Lander ES, Happi C, Gevao SM, Gnirke A, Rambaut A, Garry RF, Khan SH, Sabeti PC. 2014. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345:1369–1372. doi: 10.1126/science.1259657 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gonzalez MC, Hidalgo CA, Barabasi AL. 2008. Understanding individual human mobility patterns. Nature 453:779–782. doi: 10.1038/Nature06958 [DOI] [PubMed] [Google Scholar]
- Goodman JL. 2014. Studying “secret serums” - toward safe, effective Ebola treatments. The New England Journal of Medicine. [DOI] [PubMed] [Google Scholar]
- Gostin LO, Lucey D, Phelan A. 2014. The ebola epidemic: a global health emergency. JAMA E1–E2. doi: 10.1001/jama.2014.11176 [DOI] [PubMed] [Google Scholar]
- Grard G, Biek R, Tamfum JJM, Fair J, Wolfe N, Formenty P, Paweska J, Leroy E. 2011. Emergence of divergent Zaire Ebola virus strains in Democratic Republic of the Congo in 2007 and 2008. The Journal of Infectious Diseases 204:S776–S784. doi: 10.1093/infdis/jir364 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Groseth A, Feldmann H, Strong JE. 2007. The ecology of Ebola virus. Trends in Microbiology 15:408–416. doi: 10.1016/j.tim.2007.08.001 [DOI] [PubMed] [Google Scholar]
- Hay SI, Battle KE, Pigott DM, Smith DL, Moyes CL, Bhatt S, Brownstein JS, Collier N, Myers MF, George DB, Gething PW. 2013a. Global mapping of infectious disease. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 368:20120250. doi: 10.1098/rstb.2012.0250 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hay SI, George DB, Moyes CL, Brownstein JS. 2013b. Big data opportunities for global infectious disease surveillance. PLOS Medicine 10:e1001413. doi: 10.1371/journal.pmed.1001413 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hay SI, Tatem AJ, Graham AJ, Goetz SJ, Rogers DJ. 2006. Global environmental data for mapping infectious disease distribution. Advances in Parasitology 62:37–77. doi: 10.1016/S0065-308x(05)62002-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hayman DT, Emmerich P, Yu M, Wang LF, Suu-Ire R, Fooks AR, Cunningham AA, Wood JL. 2010. Long-term survival of an urban fruit bat seropositive for Ebola and Lagos Bat viruses. PLOS ONE 5:e11978. doi: 10.1371/journal.pone.0011978 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hayman DT, Yu M, Crameri G, Wang LF, Suu-Ire R, Wood JL, Cunningham AA. 2012. Ebola virus antibodies in fruit bats, Ghana, West Africa. Emerging Infectious Diseases 18:1207–1209. doi: 10.3201/eid1807.111654 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hewlett BS, Epelboin A, Hewlett BL, Formenty P. 2005. Medical anthropology and Ebola in Congo: cultural models and humanistic care. Bulletin de la Société de Pathologie Exotique 98:230–236 [PubMed] [Google Scholar]
- Heymann DL, Weisfeld JS, Webb PA, Johnson KM, Cairns T, Berquist H. 1980. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. The Journal of Infectious Diseases 142:372–376. doi: 10.1093/infdis/142.3.372 [DOI] [PubMed] [Google Scholar]
- Hijmans RJ. 2012. Cross-validation of species distribution models: removing spatial sorting bias and calibration with a null model. Ecology 93:679–688. doi: 10.1890/11-0826.1 [DOI] [PubMed] [Google Scholar]
- Hijmans RJ, Phillips S, Leathwick J, Elith J. 2014. dismo. R package. Accessed: August 2014. Available: http://cran.r-project.org/web/packages/dismo/dismo.pdf
- Huang ZJ, Tatem AJ. 2013. Global malaria connectivity through air travel. Malaria Journal 12:269. doi: 10.1186/1475-2875-12-269 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huete A, Didan K, Miura T, Rodriguez EP, Gao X, Ferreira LG. 2002. Overview of the radiometric and biophysical performance of the MODIS vegetation indices. Remote Sensing of Environment 83:195–213. doi: 10.1016/S0034-4257(02)00096-2 [DOI] [Google Scholar]
- Hufnagel L, Brockmann D, Geisel T. 2004. Forecast and control of epidemics in a globalized world. Proceedings of the National Academy of Sciences of USA 101:15124–15129. doi: 10.1073/pnas.0308344101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- IATA 2014. International Air Transport Association. Accessed: August 2014. Available: http://www.iata.org/Pages/default.aspx
- International Commission 1978. Ebola haemorrhagic fever in Zaire, 1976. Bulletin of the World Health Organization 56:271–293 [PMC free article] [PubMed] [Google Scholar]
- Jahrling PB, Geisbert TW, Dalgard DW, Johnson ED, Ksiazek TG, Hall WC, Peters CJ. 1990. Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet 335:502–505. doi: 10.1016/0140-6736(90)90737-P [DOI] [PubMed] [Google Scholar]
- Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P. 2008. Global trends in emerging infectious diseases. Nature 451:990–994. doi: 10.1038/Nature06536 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kamins AO, Restif O, Ntiamoa-Baidu Y, Suu-Ire R, Hayman DT, Cunningham AA, Wood JL, Rowcliffe JM. 2011. Uncovering the fruit bat bushmeat commodity chain and the true extent of fruit bat hunting in Ghana, West Africa. Biological Conservation 144:3000–3008. doi: 10.1016/j.biocon.2011.09.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Karesh WB, Dobson A, Lloyd-Smith JO, Lubroth J, Dixon MA, Bennett M, Aldrich S, Harrington T, Formenty P, Loh EH, Machalaba CC, Thomas MJ, Heymann DL. 2012. Ecology of zoonoses: natural and unnatural histories. Lancet 380:1936–1945. doi: 10.1016/S0140-6736(12)61678-X [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, Kerstiëns B, Fleerackers Y, Kilmarx PH, Rodier GR, Nkuku O, Rollin PE, Sanchez A, Zaki SR, Swanepoel R, Tomori O, Nichol ST, Peters CJ, Muyembe-Tamfum JJ, Ksiazek TG. 1999. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. The Journal of Infectious Diseases 179:S76–S86. doi: 10.1086/514306 [DOI] [PubMed] [Google Scholar]
- King AMQ, Adams MJ, Carstens EB, Lefkowitz E. 2012. Virus taxonomy: ninth report of the International Committee on Taxonomy of Viruses. London: Elsevier; p. 1338 [Google Scholar]
- Kuhn JH. 2008. Filoviruses: a compendium of 40 years of epidemiological, clinical, and laboratory studies. Vienna: Springer-Verlag; p. 413. [PubMed] [Google Scholar]
- Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson KM, Kawaoka Y, Lipkin WI, Negredo AI, Netesov SV, Nichol ST, Palacios G, Peters CJ, Tenorio A, Volchkov VE, Jahrling PB. 2010. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Archives of Virology 155:2083–2103. doi: 10.1007/s00705-010-0814-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lahm SA, Kombila M, Swanepoel R, Barnes RF. 2007. Morbidity and mortality of wild animals in relation to outbreaks of Ebola haemorrhagic fever in Gabon, 1994-2003. Transactions of the Royal Society of Tropical Medicine and Hygiene 101:64–78. doi: 10.1016/j.trstmh.2006.07.002 [DOI] [PubMed] [Google Scholar]
- Lamunu M, Lutwama JJ, Kamugisha J, Opio A, Nambooze J, Ndayimirije N, Okware S. 2004. Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000-January 2001). International Journal of Infectious Diseases 8:27–37. doi: 10.1016/j.ijid.2003.04.001 [DOI] [PubMed] [Google Scholar]
- Larkin M. 2003. Ebola outbreak in the news. The Lancet Infectious Diseases 3:255. doi: 10.1016/S1473-3099(03)00584-X [DOI] [Google Scholar]
- Le Guenno B, Formenty P, Wyers M, Gounon P, Walker F, Boesch C. 1995. Isolation and partial characterization of a new strain of Ebola virus. Lancet 345:1271–1274. doi: 10.1016/S0140-6736(95)90925-7 [DOI] [PubMed] [Google Scholar]
- Legrand J, Grais RF, Boelle PY, Valleron AJ, Flahault A. 2007. Understanding the dynamics of Ebola epidemics. Epidemiology and Infection 135:610–621. doi: 10.1017/S0950268806007217 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, Lansoud-Soukate J, Capron M, Debré P, McCormick JB, Georges AJ. 2000. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355:2210–2215. doi: 10.1016/S0140-6736(00)02405-3 [DOI] [PubMed] [Google Scholar]
- Leroy EM, Epelboin A, Mondonge V, Pourrut X, Gonzalez JP, Muyembe-Tamfum JJ, Formenty P. 2009. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne and Zoonotic Diseases 9:723–728. doi: 10.1089/vbz.2008.0167 [DOI] [PubMed] [Google Scholar]
- Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Délicat A, Paweska JT, Gonzalez JP, Swanepoel R. 2005. Fruit bats as reservoirs of Ebola virus. Nature 438:575–576. doi: 10.1038/438575a [DOI] [PubMed] [Google Scholar]
- Leroy EM, Souquière S, Rouquet P, Drevet D. 2002. Re-emergence of ebola haemorrhagic fever in Gabon. Lancet 359:712–712. doi: 10.1016/S0140-6736(02)07796-6 [DOI] [PubMed] [Google Scholar]
- Linard C, Gilbert M, Snow RW, Noor AM, Tatem AJ. 2012. Population distribution, settlement patterns and accessibility across Africa in 2010. PLOS ONE 7:e31743. doi: 10.1371/journal.pone.0031743 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Linard C, Tatem AJ, Gilbert M. 2013. Modelling spatial patterns of urban growth in Africa. Applied Geography 44:23–32. doi: 10.1016/j.apgeog.2013.07.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- MacNeil A, Farnon EC, Wamala J, Okware S, Cannon DL, Reed Z, Towner JS, Tappero JW, Lutwama J, Downing R, Nichol ST, Ksiazek TG, Rollin PE. 2010. Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerging Infectious Diseases 16:1969–1972. doi: 10.3201/eid1612.100627 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Messina JP, Brady OJ, Pigott DM, Brownstein JS, Hoen AG, Hay SI. 2014. A global compendium of human dengue virus occurrence. Scientific Data 1:140004. doi: 10.1038/sdata.2014.4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mfunda IM, Røskaft E. 2010. Bushmeat hunting in Serengeti, Tanzania: an important economic activity to local people. International Journal of Biodiversity and Conservation 2:263–272 [Google Scholar]
- Milleliri JM, Tevi-Benissan C, Baize S, Leroy E, Georges-Courbot MC. 2004. [Epidemics of Ebola haemorrhagic fever in Gabon (1994-2002). Epidemiologic aspects and considerations on control measures]. Bulletin de la Société de Pathologie Exotique 97:199–205 [PubMed] [Google Scholar]
- Miranda ME, White ME, Dayrit MM, Hayes CG, Ksiazek TG, Burans JP. 1991. Seroepidemiological study of filovirus related to Ebola in the Philippines. Lancet 337:425–426. doi: 10.1016/0140-6736(91)91199-5 [DOI] [PubMed] [Google Scholar]
- MSF 2014. Ebola epidemic confirmed in Democratic Republic of Congo: MSF sends specialists and material to the epicentre. Accessed: August 2014. Available: http://www.msf.org/article/ebola-epidemic-confirmed-democratic-republic-congo-msf-sends-specialists-and-material
- Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, Dansereau EA, Graetz N, Barber RM, Brown JC, Wang H, Duber HC, Naghavi M, Dicker D, Dandona L, Salomon JA, Heuton KR, Foreman K, Phillips DE, Fleming TD, Flaxman AD, Phillips BK, Johnson EK, Coggeshall MS, Abd-Allah F, Abera SF, Abraham JP, Abubakar I, Abu-Raddad LJ, Abu-Rmeileh NM, Achoki T, Adeyemo AO, Adou AK, Adsuar JC, Agardh EE, Akena D, Al Kahbouri MJ, Alasfoor D, Albittar MI, Alcalá-Cerra G, Alegretti MA, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Alla F, Allen PJ, Alsharif U, Alvarez E, Alvis-Guzman N, Amankwaa AA, Amare AT, Amini H, Ammar W, Anderson BO, Antonio CA, Anwari P, Arnlöv J, Arsenijevic VS, Artaman A, Asghar RJ, Assadi R, Atkins LS, Badawi A, Balakrishnan K, Banerjee A, Basu S, Beardsley J, Bekele T, Bell ML, Bernabe E, Beyene TJ, Bhala N, Bhalla A, Bhutta ZA, Abdulhak AB, Binagwaho A, Blore JD, Bose D, Brainin M, Breitborde N, Castañeda-Orjuela CA, Catalá-López F, Chadha VK, Chang JC, Chiang PP, Chuang TW, Colomar M, Cooper LT, Cooper C, Courville KJ, Cowie BC, Criqui MH, Dandona R, Dayama A, De Leo D, Degenhardt L, Del Pozo-Cruz B, Deribe K, Des Jarlais DC, Dessalegn M, Dharmaratne SD, Dilmen U, Ding EL, Driscoll TR, Durrani AM, Ellenbogen RG, Ermakov SP, Esteghamati A, Faraon EJ, Farzadfar F, Fereshtehnejad SM, Fijabi DO, Forouzanfar MH, Fra Paleo U, Gaffikin L, Gamkrelidze A, Gankpé FG, Geleijnse JM, Gessner BD, Gibney KB, Ginawi IA, Glaser EL, Gona P, Goto A, Gouda HN, Gugnani HC, Gupta R, Gupta R, Hafezi-Nejad N, Hamadeh RR, Hammami M, Hankey GJ, Harb HL, Haro JM, Havmoeller R, Hay SI, Hedayati MT, Pi IB, Hoek HW, Hornberger JC, Hosgood HD, Hotez PJ, Hoy DG, Huang JJ, Iburg KM, Idrisov BT, Innos K, Jacobsen KH, Jeemon P, Jensen PN, Jha V, Jiang G, Jonas JB, Juel K, Kan H, Kankindi I, Karam NE, Karch A, Karema CK, Kaul A, Kawakami N, Kazi DS, Kemp AH, Kengne AP, Keren A, Kereselidze M, Khader YS, Khalifa SE, Khan EA, Khang YH, Khonelidze I, Kinfu Y, Kinge JM, Knibbs L, Kokubo Y, Kosen S, Defo BK, Kulkarni VS, Kulkarni C, Kumar K, Kumar RB, Kumar GA, Kwan GF, Lai T, Balaji AL, Lam H, Lan Q, Lansingh VC, Larson HJ, Larsson A, Lee JT, Leigh J, Leinsalu M, Leung R, Li Y, Li Y, De Lima GM, Lin HH, Lipshultz SE, Liu S, Liu Y, Lloyd BK, Lotufo PA, Machado VM, Maclachlan JH, Magis-Rodriguez C, Majdan M, Mapoma CC, Marcenes W, Marzan MB, Masci JR, Mashal MT, Mason-Jones AJ, Mayosi BM, Mazorodze TT, Mckay AC, Meaney PA, Mehndiratta MM, Mejia-Rodriguez F, Melaku YA, Memish ZA, Mendoza W, Miller TR, Mills EJ, Mohammad KA, Mokdad AH, Mola GL, Monasta L, Montico M, Moore AR, Mori R, Moturi WN, Mukaigawara M, Murthy KS, Naheed A, Naidoo KS, Naldi L, Nangia V, Narayan KM, Nash D, Nejjari C, Nelson RG, Neupane SP, Newton CR, Ng M, Nisar MI, Nolte S, Norheim OF, Nowaseb V, Nyakarahuka L, Oh IH, Ohkubo T, Olusanya BO, Omer SB, Opio JN, Orisakwe OE, Pandian JD, Papachristou C, Caicedo AJ, Patten SB, Paul VK, Pavlin BI, Pearce N, Pereira DM, Pervaiz A, Pesudovs K, Petzold M, Pourmalek F, Qato D, Quezada AD, Quistberg DA, Rafay A, Rahimi K, Rahimi-Movaghar V, Rahman SU, Raju M, Rana SM, Razavi H, Reilly RQ, Remuzzi G, Richardus JH, Ronfani L, Roy N, Sabin N, Saeedi MY, Sahraian MA, Samonte GM, Sawhney M, Schneider IJ, Schwebel DC, Seedat S, Sepanlou SG, Servan-Mori EE, Sheikhbahaei S, Shibuya K, Shin HH, Shiue I, Shivakoti R, Sigfusdottir ID, Silberberg DH, Silva AP, Simard EP, Singh JA, Skirbekk V, Sliwa K, Soneji S, Soshnikov SS, Sreeramareddy CT, Stathopoulou VK, Stroumpoulis K, Swaminathan S, Sykes BL, Tabb KM, Talongwa RT, Tenkorang EY, Terkawi AS, Thomson AJ, Thorne-Lyman AL, Towbin JA, Traebert J, Tran BX, Dimbuene ZT, Tsilimbaris M, Uchendu US, Ukwaja KN, Vallely AJ, Vasankari TJ, Venketasubramanian N, Violante FS, Vlassov VV, Waller S, Wallin MT, Wang L, Wang SX, Wang Y, Weichenthal S, Weiderpass E, Weintraub RG, Westerman R, White RA, Wilkinson JD, Williams TN, Woldeyohannes SM, Wong JQ, Xu G, Yang YC, Yano Y, Yip P, Yonemoto N, Yoon SJ, Younis M, Yu C, Jin KY, El Sayed Zaki M, Zhao Y, Zheng Y, Zhou M, Zhu J, Zou XN, Lopez AD, Vos T. 2014. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. doi: 10.1016/S0140-6736(14)60844-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Laden F, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Levinson D, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mock C, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA, III, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leòn FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiebe N, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, AlMazroa MA, Memish ZA. 2012. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197–2223. doi: 10.1016/S0140-6736(12)61689-4 [DOI] [PubMed] [Google Scholar]
- Muyembe T, Kipasa M. 1995. Ebola haemorrhagic fever in Kikwit, Zaire. International Scientific and Technical Committee and WHO Collaborating Centre for Haemorrhagic Fevers. Lancet 345:1448. doi: 10.1016/S0140-6736(95)92640-2 [DOI] [PubMed] [Google Scholar]
- NCBI 2014. GenBank - ebola. Accessed: August 2014. Available: http://www.ncbi.nlm.nih.gov/genbank/
- Negredo A, Palacios G, Vazquez-Moron S, Gonzalez F, Dopazo H, Molero F, Juste J, Quetglas J, Savji N, de la Cruz Martínez M, Herrera JE, Pizarro M, Hutchison SK, Echevarría JE, Lipkin WI, Tenorio A. 2011. Discovery of an ebolavirus-like filovirus in Europe. PLOS Pathogens 7:e1002304. doi: 10.1371/journal.ppat.1002304 [DOI] [PMC free article] [PubMed] [Google Scholar]
- NIH 2014. NIAID emerging infectious diseases/pathogens. Available: Accessed: August 2014 [Google Scholar]
- Nkoghe D, Formenty P, Leroy EM, Nnegue S, Edou SY, Ba JI, Allarangar Y, Cabore J, Bachy C, Andraghetti R, de Benoist AC, Galanis E, Rose A, Bausch D, Reynolds M, Rollin P, Choueibou C, Shongo R, Gergonne B, Koné LM, Yada A, Roth C, Mve MT. 2005. [Multiple Ebola virus haemorrhagic fever outbreaks in Gabon, from October 2001 to April 2002]. Bulletin de la Société de Pathologie Exotique 98:224–229 [PubMed] [Google Scholar]
- Nkoghe D, Kone ML, Yada A, Leroy E. 2011. A limited outbreak of Ebola haemorrhagic fever in Etoumbi, Republic of Congo, 2005. Transactions of the Royal Society of Tropical Medicine and Hygiene 105:466–472. doi: 10.1016/j.trstmh.2011.04.011 [DOI] [PubMed] [Google Scholar]
- Okware SI, Omaswa FG, Zaramba S, Opio A, Lutwama JJ, Kamugisha J, Rwaguma EB, Kagwa P, Lamunu M. 2002. An outbreak of Ebola in Uganda. Tropical Medicine & International Health 7:1068–1075. doi: 10.1046/j.1365-3156.2002.00944.x [DOI] [PubMed] [Google Scholar]
- Olival KJ, Hayman DT. 2014. Filoviruses in bats: current knowledge and future directions. Viruses 6:1759–1788. doi: 10.3390/V6041759 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Onyango CO, Opoka ML, Ksiazek TG, Formenty P, Ahmed A, Tukei PM, Sang RC, Ofula VO, Konongoi SL, Coldren RL, Grein T, Legros D, Bell M, De Cock KM, Bellini WJ, Towner JS, Nichol ST, Rollin PE. 2007. Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004. The Journal of Infectious Diseases 196:S193–S198. doi: 10.1086/520609 [DOI] [PubMed] [Google Scholar]
- ORNL DAAC 2000. Shuttle radar topography mission near-global digital elevation models. Accessed: August 2014. Available: http://webmap.ornl.gov/wcsdown/wcsdown.jsp?dg_id=10008_1
- Pattyn S, Jacob W, Vandergroen G, Piot P, Courteille G. 1977. Isolation of Marburg-like virus from a case of hemorrhagic fever in Zaire. Lancet 1:573–574. doi: 10.1016/S0140-6736(77)92002-5 [DOI] [PubMed] [Google Scholar]
- Peterson AT, Bauer JT, Mills JN. 2004a. Ecologic and geographic distribution of filovirus disease. Emerging Infectious Diseases 10:40–47. doi: 10.3201/eid1001.030125 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peterson AT, Carroll DS, Mills JN, Johnson KM. 2004b. Potential mammalian filovirus reservoirs. Emerging Infectious Diseases 10:2073–2081. doi: 10.3201/eid1012.040346 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peterson AT, Papes M, Carroll DS, Leirs H, Johnson KM. 2007. Mammal taxa constituting potential coevolved reservoirs of filoviruses. Journal of Mammalogy 88:1544–1554. doi: 10.1644/06-Mamm-a-280r1.1 [DOI] [Google Scholar]
- Petter JJ, Desbordes F. 2013. Primates of the world. Princeton: Princeton University Press; p. 186 [Google Scholar]
- Phillips SJ, Dudik M, Elith J, Graham CH, Lehmann A, Leathwick J, Ferrier S. 2009. Sample selection bias and presence-only distribution models: implications for background and pseudo-absence data. Ecological Applications 19:181–197. doi: 10.1890/07-2153.1 [DOI] [PubMed] [Google Scholar]
- Pigott DM, Bhatt S, Golding N, Duda KA, Battle KE, Brady OJ, Messina JP, Balard Y, Bastien P, Pratlong F, Brownstein JS, Freifeld C, Mekaru SR, Gething PW, George DB, Myers MF, Reithinger R, Hay SI. 2014. Global distribution maps of the leishmaniases. eLife e02851. doi: 10.7554/eLife.02851 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pindolia DK, Garcia AJ, Huang ZJ, Fik T, Smith DL, Tatem AJ. 2014. Quantifying cross-border movements and migrations for guiding the strategic planning of malaria control and elimination. Malaria Journal 13:169. doi: 10.1186/1475-2875-13-169 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pourrut X, Delicat A, Rollin PE, Ksiazek TG, Gonzalez JP, Leroy EM. 2007. Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. The Journal of Infectious Diseases 196:S176–S183. doi: 10.1086/520541 [DOI] [PubMed] [Google Scholar]
- Pourrut X, Kumulungui B, Wittmann T, Moussavou G, Délicat A, Yaba P, Nkoghe D, Gonzalez JP, Leroy EM. 2005. The natural history of Ebola virus in Africa. Microbes and Infection 7:1005–1014. doi: 10.1016/j.micinf.2005.04.006 [DOI] [PubMed] [Google Scholar]
- Pourrut X, Souris M, Towner JS, Rollin PE, Nichol ST, Gonzalez JP, Leroy E. 2009. Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infectious Diseases 9:e159. doi: 10.1186/1471-2334-9-159 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rouquet P, Froment JM, Bermejo M, Kilbourn A, Karesh W, Reed P, Kumulungui B, Yaba P, Délicat A, Rollin PE, Leroy EM. 2005. Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003. Emerging Infectious Diseases 11:283–290. doi: 10.3201/eid1102.040533 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schipper J, Chanson JS, Chiozza F, Cox NA, Hoffmann M, Katariya V, Lamoreux J, Rodrigues AS, Stuart SN, Temple HJ, Baillie J, Boitani L, Lacher TE, Jnr, Mittermeier RA, Smith AT, Absolon D, Aguiar JM, Amori G, Bakkour N, Baldi R, Berridge RJ, Bielby J, Black PA, Blanc JJ, Brooks TM, Burton JA, Butynski TM, Catullo G, Chapman R, Cokeliss Z, Collen B, Conroy J, Cooke JG, da Fonseca GA, Derocher AE, Dublin HT, Duckworth JW, Emmons L, Emslie RH, Festa-Bianchet M, Foster M, Foster S, Garshelis DL, Gates C, Gimenez-Dixon M, Gonzalez S, Gonzalez-Maya JF, Good TC, Hammerson G, Hammond PS, Happold D, Happold M, Hare J, Harris RB, Hawkins CE, Haywood M, Heaney LR, Hedges S, Helgen KM, Hilton-Taylor C, Hussain SA, Ishii N, Jefferson TA, Jenkins RK, Johnston CH, Keith M, Kingdon J, Knox DH, Kovacs KM, Langhammer P, Leus K, Lewison R, Lichtenstein G, Lowry LF, Macavoy Z, Mace GM, Mallon DP, Masi M, McKnight MW, Medellín RA, Medici P, Mills G, Moehlman PD, Molur S, Mora A, Nowell K, Oates JF, Olech W, Oliver WR, Oprea M, Patterson BD, Perrin WF, Polidoro BA, Pollock C, Powel A, Protas Y, Racey P, Ragle J, Ramani P, Rathbun G, Reeves RR, Reilly SB, Reynolds JE, III, Rondinini C, Rosell-Ambal RG, Rulli M, Rylands AB, Savini S, Schank CJ, Sechrest W, Self-Sullivan C, Shoemaker A, Sillero-Zubiri C, De Silva N, Smith DE, Srinivasulu C, Stephenson PJ, van Strien N, Talukdar BK, Taylor BL, Timmins R, Tirira DG, Tognelli MF, Tsytsulina K, Veiga LM, Vié JC, Williamson EA, Wyatt SA, Xie Y, Young BE. 2008. The status of the world's land and marine mammals: diversity, threat, and knowledge. Science 322:225–230. doi: 10.1126/science.1165115 [DOI] [PubMed] [Google Scholar]
- Seto KC, Guneralp B, Hutyra LR. 2012. Global forecasts of urban expansion to 2030 and direct impacts on biodiversity and carbon pools. Proceedings of the National Academy of Sciences of USA 109:16083–16088. doi: 10.1073/pnas.1211658109 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shoemaker T, MacNeil A, Balinandi S, Campbell S, Wamala JF, McMullan LK, Downing R, Lutwama J, Mbidde E, Ströher U, Rollin PE, Nichol ST. 2012. Reemerging Sudan ebola virus disease in Uganda, 2011. Emerging Infectious Diseases 18:1480–1483. doi: 10.3201/eid1809.111536 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Siegert R, Shu H-L, Slenczka W, Peters D, Mueller G. 1967. Zur Ätiologie einer unbekannten, von Affen ausgegangenen menschlichen Infektionskrankheit. Deutsche Medizinische Wochenschrift 92:2341–2343. doi: 10.1055/s-0028-1106144 [DOI] [PubMed] [Google Scholar]
- Simini F, Gonzalez MC, Maritan A, Barabasi AL. 2012. A universal model for mobility and migration patterns. Nature 484:96–100. doi: 10.1038/nature10856 [DOI] [PubMed] [Google Scholar]
- Simini F, Maritan A, Neda Z. 2013. Human mobility in a continuum approach. PLOS ONE 8:e60069. doi: 10.1371/journal.pone.0060069 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sinka ME, Bangs MJ, Manguin S, Rubio-Palis Y, Chareonviriyaphap T, Coetzee M, Mbogo CM, Hemingway J, Patil AP, Temperley WH, Gething PW, Kabaria CW, Burkot TR, Harbach RE, Hay SI. 2012. A global map of dominant malaria vectors. Parasites & Vectors 5:69. doi: 10.1186/1756-3305-5-69 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith DH, Isaacson M, Johnson KM, Bagshawe A, Johnson BK, Swanapoel R, Killey M, Siongok T, Keruga WK. 1982. Marburg virus disease in Kenya. Lancet 1:816–820. doi: 10.1016/S0140-6736(82)91871-2 [DOI] [PubMed] [Google Scholar]
- Stockwell D, Peters D. 1999. The GARP modelling system: problems and solutions to automated spatial prediction. International Journal of Geographical Information Science 13:143–158. doi: 10.1080/136588199241391 [DOI] [Google Scholar]
- Stoddard ST, Morrison AC, Vazquez-Prokopec GM, Soldan VP, Kochel TJ, Kitron U, Elder JP, Scott TW. 2009. The role of human movement in the transmission of vector-borne pathogens. PLOS Neglected Tropical Diseases 3:e481. doi: 10.1371/journal.pntd.0000481 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Talbi C, Lemey P, Suchard MA, Abdelatif E, Elharrak M, Nourlil J, Faouzi A, Echevarría JE, Vazquez Morón S, Rambaut A, Campiz N, Tatem AJ, Holmes EC, Bourhy H. 2010. Phylodynamics and human-mediated dispersal of a zoonotic virus. PLOS Pathogens 6:e1001166. doi: 10.1371/journal.ppat.1001166 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tatem AJ, Goetz SJ, Hay SI. 2004. Terra and aqua: new data for epidemiology and public health. International Journal of Applied Earth Observation and Geoinformation 6:33–46. doi: 10.1016/j.jag.2004.07.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tignor GH, Casals J, Shope RE. 1993. The Yellow Fever epidemic in Ethiopia, 1961-1962-retrospective serological evidence for concomitant Ebola or Ebola-like virus infection. Transactions of the Royal Society of Tropical Medicine and Hygiene 87:162–162. doi: 10.1016/0035-9203(93)90471-2 [DOI] [PubMed] [Google Scholar]
- Towner JS, Amman BR, Sealy TK, Carroll SAR, Comer JA, Kemp A, Swanepoel R, Paddock CD, Balinandi S, Khristova ML, Formenty PB, Albarino CG, Miller DM, Reed ZD, Kayiwa JT, Mills JN, Cannon DL, Greer PW, Byaruhanga E, Farnon EC, Atimnedi P, Okware S, Katongole-Mbidde E, Downing R, Tappero JW, Zaki SR, Ksiazek TG, Nichol ST, Rollin PE. 2009. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLOS Pathogens 5:e1000536. doi: 10.1371/journal.ppat.1000536 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Towner JS, Khristova ML, Sealy TK, Vincent MJ, Erickson BR, Bawiec DA, Hartman AL, Comer JA, Zaki SR, Ströher U, Gomes da Silva F, del Castillo F, Rollin PE, Ksiazek TG, Nichol ST. 2006. Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. Journal of Virology 80: 6497–6516. doi: 10.1128/JVI.00069-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Towner JS, Sealy TK, Khristova ML, Albarino CG, Conlan S, Reeder SA, Quan PL, Lipkin WI, Downing R, Tappero JW, Okware S, Lutwama J, Bakamutumaho B, Kayiwa J, Comer JA, Rollin PE, Ksiazek TG, Nichol ST. 2008. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLOS Pathogens 4:e1000212. doi: 10.1371/journal.ppat.1000212 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Trabucco A, Zomer RJ. 2009. Global Aridity Index (Global-Aridity) and global potential Evapo-Transpiration (Global-PET) Geospatial database. Accessed: August 2014. Available: http://www.csi.cgiar.org
- Walsh PD, Bermejo M, Rodriguez-Teijeiro JD. 2009. Disease avoidance and the evolution of primate social connectivity: Ebola, bats, gorillas, and chimpanzees. In: Huffman MA, Chapman CA, editors. Primate parasite ecology: the dynamics and study of host-parasite relationships. Cambridge: Cambridge University Press; p. 183–197 [Google Scholar]
- Wamala JF, Lukwago L, Malimbo M, Nguku P, Yoti Z, Musenero M, Amone J, Mbabazi W, Nanyunja M, Zaramba S, Opio A, Lutwama JJ, Talisuna AO, Okware SI. 2010. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008. Emerging Infectious Diseases 16:1087–1092. doi: 10.3201/eid1607.091525 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wan ZM, Li ZL. 1997. A physics-based algorithm for retrieving land-surface emissivity and temperature from EOS/MODIS data. IEEE Transactions on Geoscience and Remote Sensing 35:980–996. doi: 10.1109/36.602541 [DOI] [Google Scholar]
- Wang H, Liddell CA, Coates MM, Mooney MD, Levitz CE, Schumacher AE, Apfel H, Iannarone M, Phillips B, Lofgren KT, Sandar L, Dorrington RE, Rakovac I, Jacobs TA, Liang X, Zhou M, Zhu J, Yang G, Wang Y, Liu S, Li Y, Ozgoren AA, Abera SF, Abubakar I, Achoki T, Adelekan A, Ademi Z, Alemu ZA, Allen PJ, Almazroa MA, Alvarez E, Amankwaa AA, Amare AT, Ammar W, Anwari P, Cunningham SA, Asad MM, Assadi R, Banerjee A, Basu S, Bedi N, Bekele T, Bell ML, Bhutta Z, Blore J, Basara BB, Boufous S, Breitborde N, Bruce NG, Bui LN, Carapetis JR, Cárdenas R, Carpenter DO, Caso V, Castro RE, Catalá-Lopéz F, Cavlin A, Che X, Chiang PP, Chowdhury R, Christophi CA, Chuang TW, Cirillo M, da Costa Leite I, Courville KJ, Dandona L, Dandona R, Davis A, Dayama A, Deribe K, Dharmaratne SD, Dherani MK, Dilmen U, Ding EL, Edmond KM, Ermakov SP, Farzadfar F, Fereshtehnejad SM, Fijabi DO, Foigt N, Forouzanfar MH, Garcia AC, Geleijnse JM, Gessner BD, Goginashvili K, Gona P, Goto A, Gouda HN, Green MA, Greenwell KF, Gugnani HC, Gupta R, Hamadeh RR, Hammami M, Harb HL, Hay S, Hedayati MT, Hosgood HD, Hoy DG, Idrisov BT, Islami F, Ismayilova S, Jha V, Jiang G, Jonas JB, Juel K, Kabagambe EK, Kazi DS, Kengne AP, Kereselidze M, Khader YS, Khalifa SE, Khang YH, Kim D, Kinfu Y, Kinge JM, Kokubo Y, Kosen S, Defo BK, Kumar GA, Kumar K, Kumar RB, Lai T, Lan Q, Larsson A, Lee JT, Leinsalu M, Lim SS, Lipshultz SE, Logroscino G, Lotufo PA, Lunevicius R, Lyons RA, Ma S, Mahdi AA, Marzan MB, Mashal MT, Mazorodze TT, McGrath JJ, Memish ZA, Mendoza W, Mensah GA, Meretoja A, Miller TR, Mills EJ, Mohammad KA, Mokdad AH, Monasta L, Montico M, Moore AR, Moschandreas J, Msemburi WT, Mueller UO, Muszynska MM, Naghavi M, Naidoo KS, Narayan KV, Nejjari C, Ng M, de Dieu Ngirabega J, Nieuwenhuijsen MJ, Nyakarahuka L, Ohkubo T, Omer SB, Caicedo AJ, Wyk VP, Pope D, Prabhakaran D, Rahman SU, Rana SM, Reilly RQ, Rojas-Rueda D, Ronfani L, Rushton L, Saeedi MY, Salomon J, Sampson U, Santos IS, Sawhney M, Schmidt JC, Shakh-Nazarova M, She J, Sheikhbahaei S, Shibuya K, Shin HH, Shishani K, Shiue I, Sigfusdottir ID, Singh JA, Skirbekk V, Sliwa K, Soshnikov SS, Sposato LA, Stathopoulou VK, Stroumpoulis K, Tabb KM, Talongwa RT, Teixeira CM, Terkawi AS, Thomson AJ, Thorne-Lyman AL, Toyoshima H, Dimbuene ZT, Uwaliraye P, Uzun SB, Vasankari TJ, Vasconcelos AM, Vlassov VV, Vollset SE, Vos T, Waller S, Wan X, Weichenthal S, Weiderpass E, Weintraub RG, Westerman R, Wilkinson JD, Williams HC, Yang YC, Yentur GK, Yip P, Yonemoto N, Younis M, Yu C, Jin KY, El Sayed Zaki M, Zhu S, Lopez AD, Murray CJ. 2014. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet:doi: 10.1016/S0140-6736(14)60497-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weiss DJ, Atkinson PM, Bhatt S, Mappin B, Hay SI, Gething PW. 2014a. An effective approach for gap-filling continental scale remotely sensed time-series. ISPRS Journal of Photogrammetry and Remote Sensing accepted manuscript [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weiss DJ, Bhatt S, Mappin B, Van Boeckel TP, Smith DL, Hay SI, Gething PW. 2014b. Air temperature suitability for Plasmodium falciparum malaria transmission in Africa 2000-2012: a high-resolution spatiotemporal prediction. Malaria Journal 13:171. doi: 10.1186/1475-2875-13-171 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wenger SJ, Olden JD. 2012. Assessing transferability of ecological models: an underappreciated aspect of statistical validation. Methods in Ecology and Evolution 3:260–267. doi: 10.1111/j.2041-210X.2011.00170.x [DOI] [Google Scholar]
- Wesolowski A, Buckee CO, Pindolia DK, Eagle N, Smith DL, Garcia AJ, Tatem AJ. 2013. The use of census migration data to approximate human movement patterns across temporal scales. PLOS ONE 8:e52971. doi: 10.1371/journal.pone.0052971 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wesolowski A, Eagle N, Tatem AJ, Smith DL, Noor AM, Snow RW, Buckee CO. 2012. Quantifying the impact of human mobility on malaria. Science 338:267–270. doi: 10.1126/science.1223467 [DOI] [PMC free article] [PubMed] [Google Scholar]
- WHO 2001. Outbreak of Ebola haemorrhagic fever, Uganda, August 2000-January 2001. Weekly Epidemiological Record 76:41–46 [PubMed] [Google Scholar]
- WHO 2003a. Outbreak(s) of Ebola haemorrhagic fever, Congo and Gabon, October 2001-July 2002. Weekly Epidemiological Record 78:223–228 [PubMed] [Google Scholar]
- WHO 2003b. Outbreak(s) of Ebola haemorrhagic fever in the Republic of the Congo, January-April 2003. Weekly Epidemiological Record 78:285–289 [PubMed] [Google Scholar]
- WHO 2005. Outbreak of Ebola haemorrhagic fever in Yambio, south Sudan, April - June 2004. Weekly Epidemiological Record 80:370–375 [PubMed] [Google Scholar]
- WHO 2012a. Ebola in Uganda - 29 July 2012. Accessed: August 2014. Available: http://www.who.int/csr/don/2012_07_29/en/
- WHO 2012b. Ebola outbreak in democratic Republic of Congo - 17 August 2012. Accessed: August 2014. Available: http://www.who.int/csr/don/2012_08_18/en/
- WHO 2012c. Ebola in Uganda - 17 November 2012. Accessed: August 2014. Available: http://www.who.int/csr/don/2012_11_17/en/
- WHO 2014a. Ebola virus disease update - west Africa. Accessed: August 2014. Available: http://www.who.int/csr/don/2014_08_15_ebola/en/
- WHO 2014b. Health statistics and information systems - definition of region groupings. Accessed: August 2014. Available: http://www.who.int/healthinfo/global_burden_disease/definition_regions/en/
- WHO 2014c. Interim manual - Ebola and Marburg virus disease epidemics: preparedness, alert, control, and evaluation. Geneva: World Health Organization; P. 123 [Google Scholar]
- WHO 2014d. WHO statement on the meeting of the International Health Regulations Emergency Committee regarding the 2014 Ebola outbreak in West Africa. Accessed: August 2014. Available: http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/
- WHO International Study Team 1978. Ebola haemorrhagic fever in Sudan, 1976. Bulletin of the World Health Organization 56:247–270 [PMC free article] [PubMed] [Google Scholar]
- Wittmann TJ, Biek R, Hassanin A, Rouquet P, Reed P, Yaba P, Pourrut X, Real LA, Gonzalez JP, Leroy EM. 2007. Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants. Proceedings of the National Academy of Sciences of USA 104:17123–17127. doi: 10.1073/pnas.0704076104 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolfe ND, Daszak P, Kilpatrick AM, Burke DS. 2005. Bushmeat Hunting, deforestation, and prediction of zoonotic disease emergence. Emerging Infectious Diseases 11:1822–1827. doi: 10.3201/eid1112.040789 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolfe ND, Dunavan CP, Diamond J. 2007. Origins of major human infectious diseases. Nature 447:279–283. doi: 10.1038/Nature05775 [DOI] [PMC free article] [PubMed] [Google Scholar]
- World Bank 2014. World Bank open dataset. Accessed: July 2014. Available: http://data.worldbank.org/
- WorldPop 2014. WorldPop project. Accessed: August 2014. Available: http://www.worldpop.org.uk/
- WWF 2014. List of terrestrial ecoregions. Accessed: August 2014. Available: http://wwf.panda.org/about_our_earth/ecoregions/ecoregion_list/
- Yang Y, Atkinson P, Ettema D. 2008. Individual space-time activity-based modelling of infectious disease transmission within a city. Journal of the Royal Society, Interface 5:759–772. doi: 10.1098/rsif.2007.1218 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zipf GK. 1946. The P1 P2/D hypothesis: on the intercity movement of persons. American Sociological Review 11:677–686. doi: 10.2307/2087063 [DOI] [Google Scholar]